CN110452169B - Method for constructing tetrahydroisoquinoline compounds - Google Patents
Method for constructing tetrahydroisoquinoline compounds Download PDFInfo
- Publication number
- CN110452169B CN110452169B CN201910785125.2A CN201910785125A CN110452169B CN 110452169 B CN110452169 B CN 110452169B CN 201910785125 A CN201910785125 A CN 201910785125A CN 110452169 B CN110452169 B CN 110452169B
- Authority
- CN
- China
- Prior art keywords
- compound
- mmol
- added
- formula
- equiv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 19
- 125000003039 tetrahydroisoquinolinyl group Chemical class C1(NCCC2=CC=CC=C12)* 0.000 title claims abstract 3
- 150000001875 compounds Chemical class 0.000 claims abstract description 51
- 238000002360 preparation method Methods 0.000 claims abstract description 22
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 173
- UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical compound OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 claims description 78
- 239000002904 solvent Substances 0.000 claims description 72
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 claims description 61
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 claims description 61
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 43
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 claims description 39
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 claims description 26
- 238000006243 chemical reaction Methods 0.000 claims description 23
- 125000006527 (C1-C5) alkyl group Chemical class 0.000 claims description 22
- 229910052739 hydrogen Inorganic materials 0.000 claims description 22
- 239000001257 hydrogen Substances 0.000 claims description 21
- 239000003446 ligand Substances 0.000 claims description 18
- 125000004185 ester group Chemical group 0.000 claims description 16
- 150000002431 hydrogen Chemical class 0.000 claims description 15
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 13
- 239000003054 catalyst Substances 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 10
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 claims description 10
- -1 silver tetrafluoroborate Chemical compound 0.000 claims description 10
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 claims description 8
- 125000006726 (C1-C5) alkenyl group Chemical class 0.000 claims description 8
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 claims description 7
- ZXMGHDIOOHOAAE-UHFFFAOYSA-N 1,1,1-trifluoro-n-(trifluoromethylsulfonyl)methanesulfonamide Chemical compound FC(F)(F)S(=O)(=O)NS(=O)(=O)C(F)(F)F ZXMGHDIOOHOAAE-UHFFFAOYSA-N 0.000 claims description 7
- 229910052736 halogen Inorganic materials 0.000 claims description 7
- 150000002367 halogens Chemical class 0.000 claims description 7
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims description 6
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 claims description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical group CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 6
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 6
- 150000002148 esters Chemical group 0.000 claims description 6
- 150000007524 organic acids Chemical class 0.000 claims description 6
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 claims description 6
- 229910052709 silver Inorganic materials 0.000 claims description 6
- 239000004332 silver Substances 0.000 claims description 6
- 229940071536 silver acetate Drugs 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- 125000003545 alkoxy group Chemical group 0.000 claims description 5
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 4
- 229940024606 amino acid Drugs 0.000 claims description 4
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 claims description 4
- ITMCEJHCFYSIIV-UHFFFAOYSA-N triflic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 230000035484 reaction time Effects 0.000 claims description 3
- ZXSQEZNORDWBGZ-UHFFFAOYSA-N 1,3-dihydropyrrolo[2,3-b]pyridin-2-one Chemical compound C1=CN=C2NC(=O)CC2=C1 ZXSQEZNORDWBGZ-UHFFFAOYSA-N 0.000 claims description 2
- AKEXVWKYUAMNKL-UHFFFAOYSA-N 2,2-dimethylpropanoic acid;silver Chemical compound [Ag].CC(C)(C)C(O)=O AKEXVWKYUAMNKL-UHFFFAOYSA-N 0.000 claims description 2
- HVFQJWGYVXKLTE-UHFFFAOYSA-N 3,5-bis(trifluoromethyl)benzoic acid Chemical compound OC(=O)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 HVFQJWGYVXKLTE-UHFFFAOYSA-N 0.000 claims description 2
- FQXQBFUUVCDIRK-UHFFFAOYSA-N 3-trifluoromethylbenzoic acid Chemical compound OC(=O)C1=CC=CC(C(F)(F)F)=C1 FQXQBFUUVCDIRK-UHFFFAOYSA-N 0.000 claims description 2
- MEXUTNIFSHFQRG-UHFFFAOYSA-N 6,7,12,13-tetrahydro-5h-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one Chemical compound C12=C3C=CC=C[C]3NC2=C2NC3=CC=C[CH]C3=C2C2=C1C(=O)NC2 MEXUTNIFSHFQRG-UHFFFAOYSA-N 0.000 claims description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 2
- KTHDTJVBEPMMGL-VKHMYHEASA-N N-acetyl-L-alanine Chemical compound OC(=O)[C@H](C)NC(C)=O KTHDTJVBEPMMGL-VKHMYHEASA-N 0.000 claims description 2
- KTHDTJVBEPMMGL-UHFFFAOYSA-N N-acetyl-L-alanine Natural products OC(=O)C(C)NC(C)=O KTHDTJVBEPMMGL-UHFFFAOYSA-N 0.000 claims description 2
- CBQJSKKFNMDLON-JTQLQIEISA-M N-acetyl-L-phenylalaninate Chemical compound CC(=O)N[C@H](C([O-])=O)CC1=CC=CC=C1 CBQJSKKFNMDLON-JTQLQIEISA-M 0.000 claims description 2
- LJLLAWRMBZNPMO-UHFFFAOYSA-N N-acetyl-beta-alanine Chemical compound CC(=O)NCCC(O)=O LJLLAWRMBZNPMO-UHFFFAOYSA-N 0.000 claims description 2
- RBYGDVHOECIAFC-UHFFFAOYSA-L acetonitrile;palladium(2+);dichloride Chemical compound [Cl-].[Cl-].[Pd+2].CC#N.CC#N RBYGDVHOECIAFC-UHFFFAOYSA-L 0.000 claims description 2
- JIMXXGFJRDUSRO-UHFFFAOYSA-N adamantane-1-carboxylic acid Chemical compound C1C(C2)CC3CC2CC1(C(=O)O)C3 JIMXXGFJRDUSRO-UHFFFAOYSA-N 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 claims description 2
- QEKREONBSFPWTQ-UHFFFAOYSA-N disilver dioxido(dioxo)tungsten Chemical compound [Ag+].[Ag+].[O-][W]([O-])(=O)=O QEKREONBSFPWTQ-UHFFFAOYSA-N 0.000 claims description 2
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical compound [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 claims description 2
- 239000011259 mixed solution Substances 0.000 claims description 2
- PBDBXAQKXCXZCJ-UHFFFAOYSA-L palladium(2+);2,2,2-trifluoroacetate Chemical compound [Pd+2].[O-]C(=O)C(F)(F)F.[O-]C(=O)C(F)(F)F PBDBXAQKXCXZCJ-UHFFFAOYSA-L 0.000 claims description 2
- 229910000073 phosphorus hydride Inorganic materials 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- 229910001958 silver carbonate Inorganic materials 0.000 claims description 2
- LKZMBDSASOBTPN-UHFFFAOYSA-L silver carbonate Substances [Ag].[O-]C([O-])=O LKZMBDSASOBTPN-UHFFFAOYSA-L 0.000 claims description 2
- 229940096017 silver fluoride Drugs 0.000 claims description 2
- REYHXKZHIMGNSE-UHFFFAOYSA-M silver monofluoride Chemical compound [F-].[Ag+] REYHXKZHIMGNSE-UHFFFAOYSA-M 0.000 claims description 2
- 229910001923 silver oxide Inorganic materials 0.000 claims description 2
- 229910001494 silver tetrafluoroborate Inorganic materials 0.000 claims description 2
- KZJPVUDYAMEDRM-UHFFFAOYSA-M silver;2,2,2-trifluoroacetate Chemical compound [Ag+].[O-]C(=O)C(F)(F)F KZJPVUDYAMEDRM-UHFFFAOYSA-M 0.000 claims description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 2
- WGTASENVNYJZBK-UHFFFAOYSA-N 3,4,5-trimethoxyamphetamine Chemical compound COC1=CC(CC(C)N)=CC(OC)=C1OC WGTASENVNYJZBK-UHFFFAOYSA-N 0.000 claims 1
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 abstract description 42
- 229940117803 phenethylamine Drugs 0.000 abstract description 21
- 238000007363 ring formation reaction Methods 0.000 abstract description 7
- 230000002194 synthesizing effect Effects 0.000 abstract description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 96
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 96
- 238000005481 NMR spectroscopy Methods 0.000 description 79
- 238000001514 detection method Methods 0.000 description 39
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 32
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical class [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 32
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 32
- 239000003480 eluent Substances 0.000 description 32
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 32
- 238000000605 extraction Methods 0.000 description 32
- 238000001914 filtration Methods 0.000 description 32
- 239000012044 organic layer Substances 0.000 description 32
- 239000003208 petroleum Substances 0.000 description 32
- 238000010898 silica gel chromatography Methods 0.000 description 32
- 125000003277 amino group Chemical group 0.000 description 9
- 239000000758 substrate Substances 0.000 description 8
- 125000001183 hydrocarbyl group Chemical group 0.000 description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 7
- OWOUKRYOZIZVFK-UHFFFAOYSA-N 2-methylphenethylamine Chemical compound CC1=CC=CC=C1CCN OWOUKRYOZIZVFK-UHFFFAOYSA-N 0.000 description 6
- 150000001412 amines Chemical class 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 150000003526 tetrahydroisoquinolines Chemical class 0.000 description 5
- 125000003342 alkenyl group Chemical group 0.000 description 4
- 150000001491 aromatic compounds Chemical class 0.000 description 4
- 125000003118 aryl group Chemical group 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 125000004433 nitrogen atom Chemical group N* 0.000 description 4
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- KPYSYYIEGFHWSV-UHFFFAOYSA-N Baclofen Chemical compound OC(=O)CC(CN)C1=CC=C(Cl)C=C1 KPYSYYIEGFHWSV-UHFFFAOYSA-N 0.000 description 3
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 229960000794 baclofen Drugs 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- FJBFPHVGVWTDIP-UHFFFAOYSA-N dibromomethane Chemical compound BrCBr FJBFPHVGVWTDIP-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 125000002524 organometallic group Chemical group 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- UWYZHKAOTLEWKK-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC=C2CNCCC2=C1 UWYZHKAOTLEWKK-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 101100391174 Dictyostelium discoideum forC gene Proteins 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- 150000003862 amino acid derivatives Chemical class 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 238000001212 derivatisation Methods 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- SASNBVQSOZSTPD-UHFFFAOYSA-N n-methylphenethylamine Chemical compound CNCCC1=CC=CC=C1 SASNBVQSOZSTPD-UHFFFAOYSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229910052763 palladium Inorganic materials 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- DREPONDJUKIQLX-UHFFFAOYSA-N 1-[ethenyl(ethoxy)phosphoryl]oxyethane Chemical compound CCOP(=O)(C=C)OCC DREPONDJUKIQLX-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- IGMRZOPJPZWRFU-UHFFFAOYSA-N 2-(2,3-dimethylphenyl)ethanamine Chemical compound CC1=CC=CC(CCN)=C1C IGMRZOPJPZWRFU-UHFFFAOYSA-N 0.000 description 1
- HFZDHWMAYFMDKY-UHFFFAOYSA-N 2-(2,4-dichlorophenyl)-n-methylethanamine Chemical compound CNCCC1=CC=C(Cl)C=C1Cl HFZDHWMAYFMDKY-UHFFFAOYSA-N 0.000 description 1
- VHJKDOLGYMULOP-UHFFFAOYSA-N 2-(2,4-dichlorophenyl)ethanamine Chemical compound NCCC1=CC=C(Cl)C=C1Cl VHJKDOLGYMULOP-UHFFFAOYSA-N 0.000 description 1
- PBWMDNDMVICFTB-UHFFFAOYSA-N 2-(2-bromophenyl)-n-methylethanamine Chemical compound CNCCC1=CC=CC=C1Br PBWMDNDMVICFTB-UHFFFAOYSA-N 0.000 description 1
- ITRNQMJXZUWZQL-UHFFFAOYSA-N 2-(2-bromophenyl)ethanamine Chemical compound NCCC1=CC=CC=C1Br ITRNQMJXZUWZQL-UHFFFAOYSA-N 0.000 description 1
- RZBOMSOHMOVUES-UHFFFAOYSA-N 2-(2-chlorophenyl)ethanamine Chemical compound NCCC1=CC=CC=C1Cl RZBOMSOHMOVUES-UHFFFAOYSA-N 0.000 description 1
- RIKUOLJPJNVTEP-UHFFFAOYSA-N 2-(2-fluorophenyl)ethanamine Chemical compound NCCC1=CC=CC=C1F RIKUOLJPJNVTEP-UHFFFAOYSA-N 0.000 description 1
- UCAUHTUMXIYKFJ-UHFFFAOYSA-N 2-(2-methoxyphenyl)-n-methylethanamine Chemical compound CNCCC1=CC=CC=C1OC UCAUHTUMXIYKFJ-UHFFFAOYSA-N 0.000 description 1
- WSWPCNMLEVZGSM-UHFFFAOYSA-N 2-(2-methoxyphenyl)ethanamine Chemical compound COC1=CC=CC=C1CCN WSWPCNMLEVZGSM-UHFFFAOYSA-N 0.000 description 1
- ZSZCXAOQVBEPME-UHFFFAOYSA-N 2-(4-bromophenyl)ethanamine Chemical compound NCCC1=CC=C(Br)C=C1 ZSZCXAOQVBEPME-UHFFFAOYSA-N 0.000 description 1
- NCBPDSPIVAMJIT-UHFFFAOYSA-N 2-(4-fluorophenyl)-n-methylethanamine Chemical compound CNCCC1=CC=C(F)C=C1 NCBPDSPIVAMJIT-UHFFFAOYSA-N 0.000 description 1
- CKLFJWXRWIQYOC-UHFFFAOYSA-N 2-(4-fluorophenyl)ethanamine Chemical compound NCCC1=CC=C(F)C=C1 CKLFJWXRWIQYOC-UHFFFAOYSA-N 0.000 description 1
- LIERORLYMWHXDL-UHFFFAOYSA-N 2-[2-(trifluoromethyl)phenyl]ethanamine Chemical compound NCCC1=CC=CC=C1C(F)(F)F LIERORLYMWHXDL-UHFFFAOYSA-N 0.000 description 1
- BPVYCXMGJPKOTQ-UHFFFAOYSA-N 2-[3-(trifluoromethyl)phenyl]ethanamine Chemical compound NCCC1=CC=CC(C(F)(F)F)=C1 BPVYCXMGJPKOTQ-UHFFFAOYSA-N 0.000 description 1
- HMFOBPNVAAAACP-UHFFFAOYSA-N 2-[4-(trifluoromethyl)phenyl]ethanamine Chemical compound NCCC1=CC=C(C(F)(F)F)C=C1 HMFOBPNVAAAACP-UHFFFAOYSA-N 0.000 description 1
- GUERDLPJJJMIEU-UHFFFAOYSA-N 3-methylphenethylamine Chemical compound CC1=CC=CC(CCN)=C1 GUERDLPJJJMIEU-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- LTPVSOCPYWDIFU-UHFFFAOYSA-N 4-methoxyphenylethylamine Chemical compound COC1=CC=C(CCN)C=C1 LTPVSOCPYWDIFU-UHFFFAOYSA-N 0.000 description 1
- VKJXAQYPOTYDLO-UHFFFAOYSA-N 4-methylphenethylamine Chemical compound CC1=CC=C(CCN)C=C1 VKJXAQYPOTYDLO-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 238000010499 C–H functionalization reaction Methods 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- DUGOZIWVEXMGBE-UHFFFAOYSA-N Methylphenidate Chemical compound C=1C=CC=CC=1C(C(=O)OC)C1CCCCN1 DUGOZIWVEXMGBE-UHFFFAOYSA-N 0.000 description 1
- JCMWSVNNSPUNER-UHFFFAOYSA-N N,O-dimethyltyramine Chemical compound CNCCC1=CC=C(OC)C=C1 JCMWSVNNSPUNER-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229940025084 amphetamine Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 150000004696 coordination complex Chemical class 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 125000006575 electron-withdrawing group Chemical group 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- SKHIBNDAFWIOPB-UHFFFAOYSA-N hydron;2-phenylethanamine;chloride Chemical compound Cl.NCCC1=CC=CC=C1 SKHIBNDAFWIOPB-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 229960001344 methylphenidate Drugs 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- JOFBJXRAJMVOGU-UHFFFAOYSA-N n-methyl-2-(2-methylphenyl)ethanamine Chemical compound CNCCC1=CC=CC=C1C JOFBJXRAJMVOGU-UHFFFAOYSA-N 0.000 description 1
- ZTXWGLLWOCJFOW-UHFFFAOYSA-N n-methyl-2-(4-methylphenyl)ethanamine Chemical compound CNCCC1=CC=C(C)C=C1 ZTXWGLLWOCJFOW-UHFFFAOYSA-N 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- 229940048346 phenethylamine hydrochloride Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000005588 protonation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/62—Isoquinoline or hydrogenated isoquinoline ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
Abstract
本申请公开了一种化合物,具有式I所示的结构式。以及该化合物的制备方法,该方法利用氨基导向的苯乙胺邻位C(sp2)–H键烯基化环化反应,从而获得了高效合成四氢异喹啉类化合物的方法。The present application discloses a compound having the structural formula shown in formula I. And the preparation method of the compound, the method utilizes amino-directed phenethylamine ortho-position C(sp 2 )-H bond alkenylation cyclization reaction, thereby obtaining a method for efficiently synthesizing tetrahydroisoquinoline compounds.
Description
技术领域technical field
本申请涉及一种化合物及其制备方法,具体地涉及一种氨基导向的苯乙胺邻位C(sp2)–H键烯基化环化的方法。The present application relates to a compound and a preparation method thereof, in particular to a method for the alkenylation and cyclization of an amino-directed phenethylamine ortho-position C(sp 2 )-H bond.
背景技术Background technique
苯乙胺是一类很重要的结构基元,存在于一些具有生物活性的分子中,如已授权的药物Amphetamine、Baclofen、Methylphenidate等,对苯乙胺的结构进行修饰能够为药物的后期衍生化或合成新药提供一定的基础,所以具有重要的意义。利用C–H活化的策略对苯乙胺进行修饰是一种快速高效的方法,目前已经有诸多报道。这些方法丰富了苯乙胺衍生化的多样性,但总的来看,这些方法都需要外加导向基团辅助,都需要先在苯乙胺上引入导向基,最后再脱除导向基,这大大地降低了合成的原子经济性和步骤经济性。Phenethylamine is a kind of very important structural motif, which exists in some biologically active molecules, such as the authorized drugs Amphetamine, Baclofen, Methylphenidate, etc. The modification of the structure of phenethylamine can be used for the later derivatization of drugs. Or the synthesis of new drugs provides a certain basis, so it is of great significance. The modification of phenethylamine by C–H activation strategy is a fast and efficient method, and many reports have been reported. These methods have enriched the diversity of phenethylamine derivatization, but in general, these methods all require the assistance of an external guiding group, and they all need to introduce a guiding group on phenethylamine first, and then remove the guiding group at last, which greatly increases the Significantly reduces the atom economy and step economy of the synthesis.
事实上氨基本身就是一个邻位导向基团,但由于氨基具有很强的配位能力,会与金属催化剂形成无催化活性的金属配合[M(RNH2)2X2](Vicente,J.;Saura-Llamas,I.;Palin,M.G.;Jones,P.G.;Ramírezde Arellano,M.C.Organometallics 1997,16,826),导致金属催化剂中毒,降低催化剂的活性(Ryabov,A.D.Chew.Rev.1990,90,403;Vicente,J.;Saura-Llamas,I.;Palin,M.G.;Jones,P.G.;Ramírez de Arellano,M.C.Organometallics1997,16,826;Font,H.;Font-Bardia,M.;Gomez,K.;Gonzalez,G.;Granell,J.;Macho,I.;Martinez,M.Dalton Trans 2014,43,13525.)。此外,还有一个原因是简单的胺,即胺基邻位有H的胺,会被氧化转化亚胺或者酮、醛类化合物。目前主要有三种方法克服以上的局限性:1)电子效应:在氮原子上引入吸电子基团(如酰基、磺酰基等),降低氮原子上电子云密度,从而降低氮原子的配位能力,同时又能作为良好的导向基团。其中静态导向基辅助的过渡金属催化脂肪胺C–H键活化发展的最为广泛。但这种方法存在着固有的弊端,就是首先需要将脂肪胺底物与导向基以共价键结合,最后还需要将导向基脱除才能得到目标产物,这样一来就降低了反应的步骤经济性和原子经济性,阻碍了其应用;2)位阻效应:用氮原子的邻位有大位阻基团的脂肪胺作反应底物。2017年Garcia等人在钯的催化下实现了对氨基α位是季碳的苯乙胺邻位C(sp2)–H键的烯基化环化(Mancinelli,A.;Alamillo,C.;Albert,J.;Ariza,X.;Etxabe,H.;Farras,J.;Garcia,J.;Granell,J.Organometallics 2017,36,911-919)。由于大位阻基团的存在,无催化活性的二胺-金属配合物便难以形成,此外,由于氨基的α位是季碳使得氨基不能够被氧化阻止了氧化副反应,但同时这也大大地局限了底物的适用范围;3)酸调控:在反应体系中加入酸,使胺与酸成盐,大大降低自由胺在反应体系中的浓度,从而抑制二胺-金属配合物的形成;同时由于氨基被质子化也能够降低氨基被氧化的副反应。In fact, the amino group itself is an ortho-directing group, but due to the strong coordination ability of the amino group, it will form a catalytically inactive metal complex with metal catalysts [M(RNH 2 ) 2 X 2 ] (Vicente, J.; Saura-Llamas, I.; Palin, MG; Jones, PG; Ramírez de Arellano, MC Organometallics 1997, 16, 826), leading to poisoning of metal catalysts and reduced catalyst activity (Ryabov, ADChew. Rev. 1990, 90, 403; Vicente, J.; Saura -Llamas, I.; Palin, MG; Jones, PG; Ramírez de Arellano, MC Organometallics 1997, 16, 826; Font, H.; Font-Bardia, M.; Gomez, K.; , I.; Martinez, M. Dalton Trans 2014, 43, 13525.). In addition, there is another reason that simple amines, that is, amines with H in the ortho-position of the amine group, can be converted into imines or ketones and aldehydes by oxidation. At present, there are three main methods to overcome the above limitations: 1) Electronic effect: introducing electron withdrawing groups (such as acyl, sulfonyl, etc.) on the nitrogen atom to reduce the electron cloud density on the nitrogen atom, thereby reducing the coordination ability of the nitrogen atom , and at the same time can be used as a good guiding group. Among them, the transition metal catalyzed activation of aliphatic amine C–H bond assisted by static directing groups is the most widely developed. However, this method has inherent drawbacks, that is, firstly, the fatty amine substrate needs to be covalently bonded to the guiding group, and finally the guiding group needs to be removed to obtain the target product, which reduces the economical step of the reaction. 2) Steric hindrance effect: aliphatic amines with large sterically hindered groups in the ortho-position of nitrogen atoms are used as reaction substrates. In 2017, Garcia et al. realized the alkenyl cyclization of the ortho-C(sp 2 )–H bond of phenethylamine with a quaternary carbon in the α-position of the para-amino group under the catalysis of palladium (Mancinelli, A.; Alamillo, C.; Albert, J.; Ariza, X.; Etxabe, H.; Farras, J.; Garcia, J.; Granell, J. Organometallics 2017, 36, 911-919). Due to the existence of large steric hindrance groups, it is difficult to form non-catalytically active diamine-metal complexes. In addition, because the α-position of the amino group is a quaternary carbon, the amino group cannot be oxidized, preventing the oxidation side reaction, but at the same time, it also greatly The scope of application of the substrate is limited; 3) Acid regulation: adding acid to the reaction system makes the amine and acid form a salt, greatly reducing the concentration of free amine in the reaction system, thereby inhibiting the formation of diamine-metal complexes; At the same time, the protonation of the amino group can also reduce the side reaction of the amino group being oxidized.
综上所述,直接使用非保护的胺基(NH2)作为导向基团,通过碳氢键活化的途径实现氨基导向的苯乙胺邻位C(sp2)–H键烯基化环化反应从而合成四氢异喹啉类化合物的报道仅有一例,但是其在适用性上存在很大的局限性,如底物则局限于无α-H的胺。所以如何获得底物不局限于无α-H的苯乙胺的烯基化环化反应,以获得实用的利用C-H键活化反应合成四氢异喹啉类化合物是需要解决的问题。In summary, the amino-directed phenethylamine ortho-C(sp 2 )–H bond alkenyl cyclization was realized by directly using the unprotected amine group (NH 2 ) as the directing group through the activation of carbon-hydrogen bonds. There is only one report on the reaction to synthesize tetrahydroisoquinoline compounds, but its applicability is very limited, for example, the substrate is limited to amines without α-H. Therefore, how to obtain the substrate is not limited to the alkenyl cyclization reaction of phenethylamine without α-H, so as to obtain the practical synthesis of tetrahydroisoquinoline compounds using the CH bond activation reaction is a problem that needs to be solved.
发明内容SUMMARY OF THE INVENTION
根据本申请的一个方面,提供了一种化合物。According to one aspect of the present application, a compound is provided.
所述化合物具有式I所示的结构式:The compound has the structural formula shown in formula I:
其中,选自芳香族化合物中芳香环上相邻的两个碳原子各失去一个氢所形成的基团;in, It is selected from the group formed by the loss of one hydrogen on each of the adjacent two carbon atoms on the aromatic ring in the aromatic compound;
R1,R2,R3,R4,R5,R7独立地选自氢、烃基、取代烃基、非烃基。R 1 , R 2 , R 3 , R 4 , R 5 , R 7 are independently selected from hydrogen, hydrocarbyl, substituted hydrocarbyl, and non-hydrocarbyl.
可选地,R1,R2,R3独立地选自氢、C1~C20的烷基、非烃基取代的C1~C20的烷基;Optionally, R 1 , R 2 , and R 3 are independently selected from hydrogen, C1-C20 alkyl, and non-hydrocarbyl-substituted C1-C20 alkyl;
R4,R5独立地选自氢、C1~C20的烷基、酯基;R 4 and R 5 are independently selected from hydrogen, C1-C20 alkyl group, and ester group;
R7选自-COOR8、-PO(OR10)2,其中R8、R10独立地选自C1~C5的烷基。R 7 is selected from -COOR 8 and -PO(OR 10 ) 2 , wherein R 8 and R 10 are independently selected from C1-C5 alkyl groups.
可选地,R4,R5至少有一个为H。Optionally, at least one of R 4 and R 5 is H.
可选地,R4,R5同时为H。Optionally, R 4 and R 5 are H at the same time.
可选地,所述化合物具有式I-1所示的结构式:Optionally, the compound has the structural formula shown in formula I-1:
可选地,R61、R62、R63、R64独立地选自氢、卤素、卤素取代的C1~C5的烷基、酯基取代的C1~C5的烯烃基、C1~C5的烷氧基;所述“酯基取代的C1~C5的烯基”中的酯基为-COOR8,其中R8为C1~C5的烷基;Optionally, R 61 , R 62 , R 63 , R 64 are independently selected from hydrogen, halogen, halogen-substituted C1-C5 alkyl, ester-substituted C1-C5 alkenyl, C1-C5 alkoxy group; the ester group in the "C1-C5 alkenyl substituted by an ester group" is -COOR 8 , wherein R 8 is a C1-C5 alkyl group;
R1选自氢、C1~C5的烷基;R 1 is selected from hydrogen, C1-C5 alkyl;
R2,R3独立地选自氢、酯基取代的C1~C5的烷基;所述“酯基取代的C1~C5的烷基”中的酯基为-COOR9,其中R9为C1~C5的烷基;R 2 and R 3 are independently selected from hydrogen and ester group-substituted C1-C5 alkyl groups; the ester group in the "ester group-substituted C1-C5 alkyl group" is -COOR 9 , wherein R 9 is C1 ~C5 alkyl;
R4,R5独立地选自氢、酯基;R 4 , R 5 are independently selected from hydrogen, ester group;
R7选自-COOR8、-PO(OR10)2,其中R8、R10独立地选自C1~C5的烷基。R 7 is selected from -COOR 8 and -PO(OR 10 ) 2 , wherein R 8 and R 10 are independently selected from C1-C5 alkyl groups.
R7可选自甲酸酯或是膦酸酯。当酯基时,为-COOR8,其中R8为C1~C5的烷基。当为膦酸酯时,为-PO(OR10)2,其中R10为C1~C5的烷基。可选地,式I所示的化合物的结构式选自以下化合物: R7 can be selected from formate or phosphonate. In the case of an ester group, it is -COOR 8 , wherein R 8 is a C1-C5 alkyl group. When it is a phosphonate, it is -PO(OR 10 ) 2 , wherein R 10 is a C1-C5 alkyl group. Optionally, the structural formula of the compound shown in formula I is selected from the following compounds:
根据本申请的另一个方面,提供一种化合物的制备方法。本申请发展了一种氨基导向的苯乙胺邻位C(sp2)–H键烯基化环化反应,从而获得了高效合成四氢异喹啉类化合物的方法。具体的讲是在具有决定性作用双三氟甲基磺酰亚胺酸的作用下,利用苯乙胺自身NH2作导向基,实现了无需外加导向基团的钯催化苯乙胺邻位C(sp2)–H键烯基化环化的反应。底物范围较广泛,α位有取代基或无取代基的苯乙胺都能适用于该反应体系,包括氨基酸酯,从而能够利用该方法合成非天然氨基酸衍生物。此外,此方法也适用于二级苯乙胺类底物。此方法能够进行放大反应。值得一提的是由酯基保护的药物分子巴氯芬的盐酸盐也能发生反应,并且以很好的收率得到相应的产物。此方法在合成具有药物活性中间体四氢异喹啉类化合物方面具有很好的合成应用前景。According to another aspect of the present application, a preparation method of a compound is provided. The present application develops an amino-directed phenethylamine ortho-position C(sp 2 )-H bond alkenylation cyclization reaction, thereby obtaining an efficient method for synthesizing tetrahydroisoquinoline compounds. Specifically, under the action of the decisive bis-trifluoromethylsulfonimide acid, the phenethylamine itself is used as NH 2 as a guide group, and the palladium-catalyzed phenethylamine ortho-C ( sp 2 )-H-bond alkenyl cyclization reaction. A wide range of substrates is available, and phenethylamine with or without substituents at the α position can be applied to the reaction system, including amino acid esters, so that the method can be used to synthesize non-natural amino acid derivatives. In addition, this method is also applicable to secondary phenethylamine substrates. This method enables scale-up reactions. It is worth mentioning that the hydrochloride salt of baclofen, a drug molecule protected by an ester group, can also react, and the corresponding product can be obtained in good yield. This method has a good synthetic application prospect in the synthesis of tetrahydroisoquinoline compounds with pharmaceutical active intermediates.
所述化合物的制备方法,包括以下步骤:The preparation method of the compound comprises the following steps:
化合物II和化合物III在含有催化剂的反应体系中反应生成式I所示的化合物;Compound II and compound III are reacted in a reaction system containing a catalyst to generate the compound shown in formula I;
化合物II的结构式如式II-1、式II-2或式II-3所示;The structural formula of compound II is shown in formula II-1, formula II-2 or formula II-3;
化合物III的结构式如式III所示;The structural formula of compound III is shown in formula III;
其中,选自芳香族化合物中芳香环上相邻的两个碳原子各失去一个氢所形成的基团;in, It is selected from the group formed by the loss of one hydrogen on each of the adjacent two carbon atoms on the aromatic ring in the aromatic compound;
R1,R2,R3,R4,R5,R7独立地选自氢、烃基、取代烃基、非烃基。R 1 , R 2 , R 3 , R 4 , R 5 , R 7 are independently selected from hydrogen, hydrocarbyl, substituted hydrocarbyl, and non-hydrocarbyl.
可选地,R1,R2,R3独立地选自氢、C1~C20的烷基、非烃基取代的C1~C20的烷基;Optionally, R 1 , R 2 , and R 3 are independently selected from hydrogen, C1-C20 alkyl, and non-hydrocarbyl-substituted C1-C20 alkyl;
R4,R5独立地选自氢、C1~C20的烷基、酯基;R 4 and R 5 are independently selected from hydrogen, C1-C20 alkyl group, and ester group;
R7选自-COOR8、-PO(OR10)2,其中R8、R10独立地选自C1~C5的烷基。R 7 is selected from -COOR 8 and -PO(OR 10 ) 2 , wherein R 8 and R 10 are independently selected from C1-C5 alkyl groups.
R7可选自甲酸酯或是膦酸酯。当甲酸酯时,为-COOR8,其中R8为C1~C5的烷基。当为膦酸酯时,为-PO(OR10)2,其中R10为C1~C5的烷基。 R7 can be selected from formate or phosphonate. When formate, it is -COOR 8 , wherein R 8 is a C1-C5 alkyl group. When it is a phosphonate, it is -PO(OR 10 ) 2 , wherein R 10 is a C1-C5 alkyl group.
可选地,R4,R5独立地选自氢、C1~C20的烷基、酯基且R4,R5至少有一个为H。Optionally, R 4 and R 5 are independently selected from hydrogen, a C1-C20 alkyl group, an ester group, and at least one of R 4 and R 5 is H.
可选地,R4,R5同时为H。Optionally, R 4 and R 5 are H at the same time.
可选地,选自苯环上相邻的两个碳原子各失去一个氢所形成的基团。Optionally, It is selected from the group formed by the loss of one hydrogen from each of the two adjacent carbon atoms on the benzene ring.
可选地,为其中R61、R62、R63、R64独立地选自氢、卤素、卤素取代的C1~C5的烷基、酯基取代的C1~C5的烯烃基、C1~C5的烷氧基;所述“酯基取代的C1~C5的烯基”中的酯基为-COOR8,其中R8为C1~C5的烷基。Optionally, for wherein R 61 , R 62 , R 63 , and R 64 are independently selected from hydrogen, halogen, halogen-substituted C1-C5 alkyl, ester-substituted C1-C5 alkenyl, and C1-C5 alkoxy; The ester group in the "C1-C5 alkenyl substituted by an ester group" is -COOR 8 , wherein R 8 is a C1-C5 alkyl group.
可选地,化合物II选自以下化合物:Optionally, compound II is selected from the following compounds:
化合物III选自以下化合物:Compound III is selected from the following compounds:
可选地,所述催化剂包括含有钯元素的化合物、含有银元素的化合物、有机酸、配体。Optionally, the catalyst includes a compound containing palladium element, a compound containing silver element, an organic acid, and a ligand.
可选地,所述含有钯元素的化合物选自醋酸钯、三氟醋酸钯、双(乙腈)氯化钯中的至少一种;Optionally, the compound containing palladium element is selected from at least one of palladium acetate, palladium trifluoroacetate and bis(acetonitrile) palladium chloride;
所述含有银元素的化合物选自碳酸银、醋酸银、氧化银、三氟醋酸银、四氟硼酸银、特戊酸银、钨酸银、氟化银中的至少一种;The compound containing silver element is selected from at least one of silver carbonate, silver acetate, silver oxide, silver trifluoroacetate, silver tetrafluoroborate, silver pivalate, silver tungstate and silver fluoride;
所述有机酸选自五氟苯甲酸、三氟乙酸、3-三氟甲基苯甲酸、三氟甲磺酸、3,5-双三氟甲基苯甲酸、1-金刚烷甲酸、乙酸、双三氟甲基磺酰亚胺酸中的至少一种;The organic acid is selected from pentafluorobenzoic acid, trifluoroacetic acid, 3-trifluoromethylbenzoic acid, trifluoromethanesulfonic acid, 3,5-bis-trifluoromethylbenzoic acid, 1-adamantanecarboxylic acid, acetic acid, At least one of bis-trifluoromethanesulfonimide acid;
所述配体选自氨基酸配体、膦配体、吡啶配体、酸配体、卡宾配体中的至少一种。The ligand is selected from at least one of amino acid ligands, phosphine ligands, pyridine ligands, acid ligands, and carbene ligands.
可选地,所述配体选自N-乙酰-L-苯丙氨酸、N-乙酰-L-丙氨酸、N-乙酰-β-丙氨酸、2-羟基吡啶中的至少一种。Optionally, the ligand is selected from at least one of N-acetyl-L-phenylalanine, N-acetyl-L-alanine, N-acetyl-β-alanine, 2-hydroxypyridine .
可选地,化合物II与含有钯元素的化合物的摩尔比为1:0.8~1.2;Optionally, the molar ratio of compound II to the compound containing palladium element is 1:0.8-1.2;
化合物II与含有银元素的化合物的摩尔比为1:2~3;The molar ratio of compound II to the compound containing silver element is 1:2~3;
化合物II与有机酸的摩尔比为1:0.8~1.2;The molar ratio of compound II to organic acid is 1:0.8~1.2;
化合物II与配体的摩尔比为1:1.8~2.2。The molar ratio of compound II to ligand is 1:1.8-2.2.
可选地,所述催化剂为醋酸钯、醋酸银、2-羟基吡啶、双三氟甲基磺酰亚胺酸;Optionally, the catalyst is palladium acetate, silver acetate, 2-hydroxypyridine, bis-trifluoromethanesulfonimide acid;
醋酸钯的摩尔数为化合物II的摩尔数的10%;The mole number of palladium acetate is 10% of the mole number of compound II;
醋酸银的摩尔数为化合物II的摩尔数的2倍当量;The mole number of silver acetate is twice the equivalent of the mole number of compound II;
2-羟基吡啶的摩尔数为化合物II的摩尔数的20%;The moles of 2-hydroxypyridine are 20% of the moles of compound II;
双三氟甲基磺酰亚胺酸的摩尔数与化合物II的摩尔数等当量。The number of moles of bis-trifluoromethanesulfonimide acid is equivalent to the number of moles of compound II.
可选地,化合物II和化合物III的摩尔比为1:1.2~2。Optionally, the molar ratio of compound II and compound III is 1:1.2-2.
可选地,所述反应体系中还包括溶剂;Optionally, the reaction system also includes a solvent;
所述溶剂选自N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、四氢呋喃、六氟异丙醇、二氯乙烷、六氟异丙醇与二氯乙烷混合液、二氯甲烷、甲醇、叔戊醇、甲苯中的至少一种。The solvent is selected from N,N-dimethylformamide, N,N-dimethylacetamide, tetrahydrofuran, hexafluoroisopropanol, dichloroethane, mixed solution of hexafluoroisopropanol and dichloroethane , at least one of dichloromethane, methanol, tert-amyl alcohol, and toluene.
可选地,所述反应体系中还包括溶剂;Optionally, the reaction system also includes a solvent;
所述溶剂为体积比为1:4~1:9的六氟异丙醇与二氯乙烷。The solvent is hexafluoroisopropanol and dichloroethane in a volume ratio of 1:4 to 1:9.
可选地,所述反应的温度为50℃~120℃,所述反应的时间为10小时~25小时。Optionally, the reaction temperature is 50°C to 120°C, and the reaction time is 10 hours to 25 hours.
可选地,所述反应的温度为80℃~90℃,所述反应的时间为12小时~24小时。Optionally, the reaction temperature is 80°C to 90°C, and the reaction time is 12 hours to 24 hours.
根据本申请的另一个方面,提供所述的方法在制备四氢异喹啉化合物中的应用。According to another aspect of the present application, the application of the method in the preparation of tetrahydroisoquinoline compounds is provided.
本申请中,三氟甲磺酸简写为HOTf;乙酸根简写为OAc;双三氟甲基磺酰亚胺酸简写为Tf2NH;六氟异丙醇简写为HFIP;二氯甲烷简写为DCM。In this application, trifluoromethanesulfonic acid is abbreviated as HOTf; acetate is abbreviated as OAc; bis-trifluoromethanesulfonimide acid is abbreviated as Tf 2 NH; hexafluoroisopropanol is abbreviated as HFIP; dichloromethane is abbreviated as DCM .
在本申请中,C1~C5、C1~C20等均是指基团中所包含的碳原子数。In this application, C1-C5, C1-C20, etc. all refer to the number of carbon atoms contained in the group.
在本申请中,术语“烃基”是指由烃类化合物分子上失去任意一个氢原子所形成的基团;所述烃类化合物包括烷烃化合物、烯烃化合物、炔烃化合物和芳烃化合物,例如甲苯失去苯环上甲基对位的氢原子所形成的对甲苯基,或甲苯失去甲基上任意一个氢原子所形成的苄基等。In this application, the term "hydrocarbyl" refers to a group formed by the loss of any hydrogen atom on the molecule of hydrocarbon compounds; the hydrocarbon compounds include alkane compounds, alkene compounds, alkyne compounds and aromatic compounds, such as toluene lost The p-tolyl group formed by the hydrogen atom in the para position of the methyl group on the benzene ring, or the benzyl group formed by the loss of any hydrogen atom on the methyl group from toluene, etc.
在本申请中,术语“烷基”是指由烷烃化合物分子上失去任意一个氢原子所形成的基团。In this application, the term "alkyl" refers to a group formed by the loss of any hydrogen atom on the molecule of an alkane compound.
在本申请中,术语“芳基”是指由芳香族化合物分子上失去芳环上的一个氢原子所形成的基团;例如甲苯失去苯环上甲基对位的氢原子所形成的对甲苯基。In this application, the term "aryl" refers to a group formed by the loss of a hydrogen atom on the aromatic ring on the molecule of an aromatic compound; for example, p-toluene formed by the loss of a hydrogen atom in the para position of the methyl group on the benzene ring. base.
在本申请中,术语“卤素”是指氟、氯、溴、碘中的至少一种。In this application, the term "halogen" refers to at least one of fluorine, chlorine, bromine, and iodine.
在本申请中,术语“非烃类取代基”是指含有除H和C以外的其他元素(例如卤素、S、O、P、N等)的化合物失去任意一个氢原子所形成的基团,例如烷氧基、卤素、硝基、氰基、酯基、羧基、羟基、羰基、磷酸酯基等。In this application, the term "non-hydrocarbon substituent" refers to a group formed by the loss of any hydrogen atom from a compound containing other elements other than H and C (such as halogen, S, O, P, N, etc.), For example, alkoxy, halogen, nitro, cyano, ester, carboxyl, hydroxyl, carbonyl, phosphate and the like.
本申请中,-Me为-CH3.In this application, -Me is -CH 3 .
本申请中,-Et为-CH2CH3。In the present application, -Et is -CH 2 CH 3 .
本申请中,-n-Bu为-CH2CH2CH2CH3。In the present application, -n-Bu is -CH 2 CH 2 CH 2 CH 3 .
本申请中,-t-Bu为叔丁基。In this application, -t-Bu is tert-butyl.
本申请能产生的有益效果包括:The beneficial effects that this application can produce include:
1)本申请所提供的化合物的制备方法,利用苯乙胺本身自有的氨基作为导向基进行导向,选择性活化邻位C(sp2)–H,从而对苯乙胺进行直接修饰,不需要外加静态导向基,具有更好的原子经济性和步骤经济性。1) The preparation method of the compound provided by this application uses the amino group of phenethylamine itself as a guiding group to guide, and selectively activates the ortho-position C(sp 2 )-H, so that the phenethylamine is directly modified without Requires additional static directing groups, which have better atom economy and step economy.
2)本申请所提供的化合物的制备方法,所适用的底物广泛,α位有取代基或无取代基的苯乙胺都能适用于该反应体系,包括氨基酸酯,从而能够利用该反应合成非天然氨基酸衍生物,适用性广泛。2) The preparation method of the compound provided by the application has a wide range of applicable substrates, and the phenethylamine with a substituent or without a substituent in the α position can be applied to the reaction system, including amino acid ester, so that the reaction can be used to synthesize. Unnatural amino acid derivatives with wide applicability.
3)本申请所提供的化合物的制备方法,能够进行放大反应,并且钯催化剂的用量可以降到2mol%至1mol%。3) The preparation method of the compound provided by the present application can carry out an enlarged reaction, and the amount of the palladium catalyst can be reduced to 2 mol% to 1 mol%.
4)本申请所提供的化合物的制备方法,对于二级苯乙胺同样适用。4) The preparation method of the compound provided in this application is also applicable to secondary phenethylamine.
5)本申请所提供的化合物的制备方法,酯基保护的药物分子巴氯芬的盐酸盐也能发生反应,并且以很好的收率得到相应的产物。5) In the preparation method of the compound provided in this application, the hydrochloride of the ester group-protected drug molecule baclofen can also react, and the corresponding product can be obtained in a good yield.
6)本申请所提供的化合物的制备方法,在构建四氢异喹啉方面有很好的应用前景。6) The preparation method of the compound provided in this application has a good application prospect in the construction of tetrahydroisoquinoline.
具体实施方式Detailed ways
下面结合实施例详述本申请,但本申请并不局限于这些实施例。The present application will be described in detail below with reference to the examples, but the present application is not limited to these examples.
如无特别说明,本申请的实施例中的原料和催化剂均通过商业途径购买。Unless otherwise specified, the raw materials and catalysts in the examples of the present application are purchased through commercial channels.
本申请的实施例中分析方法如下:The analytical method in the embodiment of the application is as follows:
核磁共振氢谱1H-NMR在布鲁克公司(Bruker)的400AVANCE III型分光仪(Spectrometer),400MHz,CDCl3和日本电子株式会社(JEOL)ECZ600S型分光仪(Spectrometer),600MHz,CDCl3上分别测定的;Proton 1 H-NMR was performed on Bruker's 400AVANCE III spectrometer (Spectrometer), 400MHz, CDCl 3 and JEOL's (JEOL) ECZ600S spectrometer (Spectrometer), 600MHz, CDCl 3 , respectively measured;
13C-NMR分别为400MHz,CDCl3和600MHz,CDCl3;高分辨质谱仪:布鲁克公司(Bruker)Impact II UHR-TOF mass spectrometry。 13 C-NMR was 400 MHz, CDCl 3 and 600 MHz, CDCl 3 respectively; high-resolution mass spectrometer: Bruker Impact II UHR-TOF mass spectrometry.
目标产物的产率通过以下公式计算得到:产率%=(目标产物实际得到的质量÷目标产物理论上应得到的质量)×100%。The yield of the target product is calculated by the following formula: Yield %=(the mass of the target product actually obtained ÷ the theoretically obtained mass of the target product)×100%.
实施例1Example 1
在空气下,往干燥的38mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,10mol%),AgOAc(66.8mg,0.4mmol,2equiv.),2-羟基吡啶(3.8mg,0.04mmol,20mol%),再在手套箱中加入Tf2NH(56.2mg,0.2mmol,1.0equiv),最后依次加入DCM(1.6mL),HFIP(0.4mL),丙烯酸乙酯(26.1μL,0.24mmol,1.2equiv)和式1-2所示的邻甲基苯乙胺(0.2mmol)。体系在90℃下反应12h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品记为1-3,共40.6mg,产率为87%。Under air, into a dry 38 mL sealed tube was added Pd(OAc) 2 (4.5 mg, 0.02 mmol, 10 mol%), AgOAc (66.8 mg, 0.4 mmol, 2 equiv.), 2-hydroxypyridine (3.8 mg, 0.04 mmol. , 20 mol%), then Tf 2 NH (56.2 mg, 0.2 mmol, 1.0 equiv) was added in the glove box, and finally DCM (1.6 mL), HFIP (0.4 mL), ethyl acrylate (26.1 μL, 0.24 mmol, 1.2 equiv) and o-methylphenethylamine of formula 1-2 (0.2 mmol). The system was reacted at 90 °C for 12 h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. The resulting product samples were denoted 1-3, a total of 40.6 mg, and a yield of 87%.
产物样品1-3的检测数据如下:The detection data of product samples 1-3 are as follows:
1H NMR(400MHz,CDCl3)δ7.09–7.01(m,2H),6.96(d,J=7.6Hz,1H),4.46(dd,J=10.0,3.2Hz,1H),4.18(q,J=7.2Hz,2H),3.23(dt,J=12.4,6.0Hz,1H),3.06(dt,J=12.4,6.0Hz,1H),2.85(dd,J=16.0,3.6Hz,1H),2.74(dd,J=16.0,10.0Hz,1H),2.71–2.58(m,2H),2.27(s,1H),2.22(s,3H),1.27(t,J=7.2Hz,3H).13C NMR(151MHz,CDCl3)δ172.5,137.6,136.9,134.1,127.9,125.5,123.8,60.7,53.1,41.4,40.39,27.3,19.5,14.3.HRMSCalcd for C14H20NO2[M+H]+234.1489,found 234.1489. 1 H NMR (400MHz, CDCl 3 ) δ 7.09-7.01 (m, 2H), 6.96 (d, J=7.6Hz, 1H), 4.46 (dd, J=10.0, 3.2Hz, 1H), 4.18 (q, J=7.2Hz, 2H), 3.23 (dt, J=12.4, 6.0Hz, 1H), 3.06 (dt, J=12.4, 6.0Hz, 1H), 2.85 (dd, J=16.0, 3.6Hz, 1H), 13 C NMR (151MHz, CDCl 3 ) δ 172.5, 137.6, 136.9, 134.1, 127.9, 125.5, 123.8, 60.7, 53.1, 41.4, 40.39, 27.3, 19.5, 14.3. HRMSCalcd for C 14 H 20 NO 2 [M+H] + 234.1489, found 234.1489.
实施例2Example 2
在空气下,往干燥的38mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,10mol%),AgOAc(66.8mg,0.4mmol,2equiv.),2-羟基吡啶(3.8mg,0.04mmol,20mol%),再在手套箱中加入Tf2NH(56.2mg,0.2mmol,1.0equiv),最后依次加入DCM(1.6mL),HFIP(0.4mL),丙烯酸乙酯(26.1μL,0.24mmol,1.2equiv)和苯乙胺(0.2mmol)。体系在90℃下反应12h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品分别记为2-3,2-4。2-3共21.5mg,产率为49%,2-4共16.5mg,产率为26%。Under air, into a dry 38 mL sealed tube was added Pd(OAc) 2 (4.5 mg, 0.02 mmol, 10 mol%), AgOAc (66.8 mg, 0.4 mmol, 2 equiv.), 2-hydroxypyridine (3.8 mg, 0.04 mmol. , 20 mol%), then Tf 2 NH (56.2 mg, 0.2 mmol, 1.0 equiv) was added in the glove box, and finally DCM (1.6 mL), HFIP (0.4 mL), ethyl acrylate (26.1 μL, 0.24 mmol, 1.2 equiv) and phenethylamine (0.2 mmol). The system was reacted at 90 °C for 12 h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. The obtained product samples were recorded as 2-3 and 2-4, respectively. The total of 2-3 was 21.5 mg with a yield of 49%, and the total of 2-4 was 16.5 mg with a yield of 26%.
产物样品2-3的检测数据如下:The detection data of product samples 2-3 are as follows:
1H NMR(400MHz,CDCl3)δ7.15–7.08(m,4H),4.46(dd,J=10.0,3.2Hz,1H),4.18(q,J=7.2Hz,2H),3.20(td,J=12.4,6.0Hz,1H),3.02(ddd,J=12.4,7.2,5.2Hz,1H),2.90–2.70(m,4H),2.29(s,1H),1.26(t,J=7.2Hz,3H).13C NMR(151MHz,CDCl3)δ172.5,137.7,135.6,129.6,126.4,126.0,60.7,52.8,41.4,40.7,29.9,14.3. 1 H NMR (400 MHz, CDCl 3 ) δ 7.15-7.08 (m, 4H), 4.46 (dd, J=10.0, 3.2 Hz, 1H), 4.18 (q, J=7.2 Hz, 2H), 3.20 (td, J=12.4, 6.0Hz, 1H), 3.02 (ddd, J=12.4, 7.2, 5.2Hz, 1H), 2.90–2.70 (m, 4H), 2.29 (s, 1H), 1.26 (t, J=7.2Hz) , 3H). 13 C NMR (151MHz, CDCl 3 )δ172.5, 137.7, 135.6, 129.6, 126.4, 126.0, 60.7, 52.8, 41.4, 40.7, 29.9, 14.3.
产物样品2-4的检测数据如下:The detection data of product samples 2-4 are as follows:
1H NMR(400MHz,CDCl3)δ7.94(d,J=15.6Hz,1H),7.43(d,J=7.2Hz,1H),7.21–7.13(m,2H),6.34(d,J=15.6Hz,1H),4.49(dd,J=9.2,3.6Hz,1H),4.27(q,J=7.2Hz,2H),4.18(q,J=7.2Hz,2H),3.36(td,J=12.4,6.0Hz,1H),3.07(td,J=12.8,6.0Hz,1H),2.93–2.74(m,4H),2.18(s,1H),1.34(t,J=7.2Hz,3H),1.27(t,J=7.2Hz,3H).13C NMR(101MHz,CDCl3)δ172.2,166.9,141.7,138.3,134.8,134.0,127.9,126.0,124.9,120.2,60.7,60.6,52.9,41.1,40.1,27.0,14.4,14.2.HRMS Calcd for C18H24NO4[M+H]+318.1700,found318.1700. 1 H NMR (400 MHz, CDCl 3 ) δ 7.94 (d, J=15.6 Hz, 1H), 7.43 (d, J=7.2 Hz, 1H), 7.21-7.13 (m, 2H), 6.34 (d, J= 15.6Hz, 1H), 4.49 (dd, J=9.2, 3.6Hz, 1H), 4.27 (q, J=7.2Hz, 2H), 4.18 (q, J=7.2Hz, 2H), 3.36 (td, J= 12.4, 6.0Hz, 1H), 3.07 (td, J=12.8, 6.0Hz, 1H), 2.93–2.74 (m, 4H), 2.18 (s, 1H), 1.34 (t, J=7.2Hz, 3H), 1.27 (t, J=7.2 Hz, 3H). 13 C NMR (101 MHz, CDCl 3 ) δ 172.2, 166.9, 141.7, 138.3, 134.8, 134.0, 127.9, 126.0, 124.9, 120.2, 60.7, 60.6, 52.9, 41.1, 40.1 ,27.0,14.4,14.2.HRMS Calcd for C 18 H 24 NO 4 [M+H] + 318.1700,found318.1700.
实施例3Example 3
在空气下,往干燥的38mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,10mol%),AgOAc(66.8mg,0.4mmol,2equiv.),2-羟基吡啶(3.8mg,0.04mmol,20mol%),再在手套箱中加入Tf2NH(56.2mg,0.2mmol,1.0equiv),最后依次加入DCM(1.6mL),HFIP(0.4mL),丙烯酸乙酯(26.1μL,0.24mmol,1.2equiv)和式3-1所示邻甲氧基苯乙胺(0.2mmol)。体系在90℃下反应12h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品记为3-3,共36.4mg,产率为73%。Under air, into a dry 38 mL sealed tube was added Pd(OAc) 2 (4.5 mg, 0.02 mmol, 10 mol%), AgOAc (66.8 mg, 0.4 mmol, 2 equiv.), 2-hydroxypyridine (3.8 mg, 0.04 mmol. , 20 mol%), then Tf 2 NH (56.2 mg, 0.2 mmol, 1.0 equiv) was added in the glove box, and finally DCM (1.6 mL), HFIP (0.4 mL), ethyl acrylate (26.1 μL, 0.24 mmol, 1.2 equiv) and o-methoxyphenethylamine of formula 3-1 (0.2 mmol). The system was reacted at 90 °C for 12 h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. The resulting product sample was designated 3-3, a total of 36.4 mg, and a yield of 73%.
产物样品3-3的检测数据如下:The detection data of product samples 3-3 are as follows:
1H NMR(400MHz,CDCl3)δ7.13(t,J=8.0Hz,1H),6.71(t,J=8.4Hz,2H),4.45(dd,J=9.6,3.2Hz,1H),4.18(q,J=7.2Hz,2H),3.82(s,3H),3.20(dt,J=12.4,6.0Hz,1H),3.01(dt,J=12.4,6.0Hz,1H),2.86(dd,J=16.0,3.2Hz,1H),2.75(dd,J=16.0,10.0Hz,1H),2.68(t,J=6.0Hz,2H),2.32(s,1H),1.27(t,J=7.2Hz,3H).13C NMR(151MHz,CDCl3)δ172.5,157.3,138.8,126.3,124.5,118.1,107.6,60.7,55.4,52.7,41.2,40.1,23.7,14.3. 1 H NMR (400 MHz, CDCl 3 ) δ 7.13 (t, J=8.0 Hz, 1H), 6.71 (t, J=8.4 Hz, 2H), 4.45 (dd, J=9.6, 3.2 Hz, 1H), 4.18 (q, J=7.2Hz, 2H), 3.82 (s, 3H), 3.20 (dt, J=12.4, 6.0Hz, 1H), 3.01 (dt, J=12.4, 6.0Hz, 1H), 2.86 (dd, J=16.0, 3.2Hz, 1H), 2.75 (dd, J=16.0, 10.0Hz, 1H), 2.68 (t, J=6.0Hz, 2H), 2.32 (s, 1H), 1.27 (t, J=7.2 Hz, 3H). 13 C NMR (151MHz, CDCl 3 )δ172.5, 157.3, 138.8, 126.3, 124.5, 118.1, 107.6, 60.7, 55.4, 52.7, 41.2, 40.1, 23.7, 14.3.
实施例4Example 4
在空气下,往干燥的38mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,10mol%),AgOAc(66.8mg,0.4mmol,2equiv.),2-羟基吡啶(3.8mg,0.04mmol,20mol%),再在手套箱中加入Tf2NH(56.2mg,0.2mmol,1.0equiv),最后依次加入DCM(1.6mL),HFIP(0.4mL),丙烯酸乙酯(26.1μL,0.24mmol,1.2equiv)和式4-1所示邻氟苯乙胺(0.2mmol)。体系在90℃下反应12h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品记为4-3,共32.3mg,产率为68%。Under air, into a dry 38 mL sealed tube was added Pd(OAc) 2 (4.5 mg, 0.02 mmol, 10 mol%), AgOAc (66.8 mg, 0.4 mmol, 2 equiv.), 2-hydroxypyridine (3.8 mg, 0.04 mmol. , 20 mol%), then Tf 2 NH (56.2 mg, 0.2 mmol, 1.0 equiv) was added in the glove box, and finally DCM (1.6 mL), HFIP (0.4 mL), ethyl acrylate (26.1 μL, 0.24 mmol, 1.2 equiv) and o-fluorophenethylamine of formula 4-1 (0.2 mmol). The system was reacted at 90 °C for 12 h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. The resulting product sample was designated as 4-3, a total of 32.3 mg, and a yield of 68%.
产物样品4-3的检测数据如下:The detection data of product samples 4-3 are as follows:
1H NMR(400MHz,CDCl3)δ7.12(dd,J=13.6,7.6Hz,1H),6.90–6.86(m,2H),4.45(dd,J=9.6,3.2Hz,1H),4.18(q,J=7.2Hz,2H),3.22(dt,J=12.0,6.4Hz,1H),3.02(dt,J=12.4,6.0Hz,1H),2.85(dd,J=16.4,3.6Hz,1H),2.78–2.72(m,3H),2.22(s,1H),1.27(t,J=7.2Hz,3H).13C NMR(151MHz,CDCl3)δ172.2,160.8(d,J=244.5Hz),140.0(d,J=5.1Hz),126.7(d,J=8.6Hz),123.3(d,J=18.6Hz),121.3(d,J=2.9Hz),112.7(d,J=21.7Hz),60.8,52.5,41.1,39.8,22.7(d,J=3.6Hz),14.3.HRMS Calcd for C13H17FNO2[M+H]+238.1238,found 238.1238. 1 H NMR (400 MHz, CDCl 3 ) δ 7.12 (dd, J=13.6, 7.6 Hz, 1H), 6.90-6.86 (m, 2H), 4.45 (dd, J=9.6, 3.2 Hz, 1H), 4.18 ( q, J=7.2Hz, 2H), 3.22 (dt, J=12.0, 6.4Hz, 1H), 3.02 (dt, J=12.4, 6.0Hz, 1H), 2.85 (dd, J=16.4, 3.6Hz, 1H) ), 2.78–2.72(m, 3H), 2.22(s, 1H), 1.27(t, J=7.2Hz, 3H). 13 C NMR(151MHz, CDCl 3 )δ172.2,160.8(d, J=244.5Hz) ,140.0(d,J=5.1Hz),126.7(d,J=8.6Hz),123.3(d,J=18.6Hz),121.3(d,J=2.9Hz),112.7(d,J=21.7Hz) ,60.8,52.5,41.1,39.8,22.7(d,J=3.6Hz),14.3.HRMS Calcd for C 13 H 17 FNO 2 [M+H] + 238.1238,found 238.1238.
实施例5Example 5
在空气下,往干燥的38mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,10mol%),AgOAc(66.8mg,0.4mmol,2equiv.),2-羟基吡啶(3.8mg,0.04mmol,20mol%),再在手套箱中加入Tf2NH(56.2mg,0.2mmol,1.0equiv),最后依次加入DCM(1.6mL),HFIP(0.4mL),丙烯酸乙酯(26.1μL,0.24mmol,1.2equiv)和式5-1所示邻氯苯乙胺(0.2mmol)。体系在90℃下反应12h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品记为5-3,共40.5mg,产率为80%。Under air, into a dry 38 mL sealed tube was added Pd(OAc) 2 (4.5 mg, 0.02 mmol, 10 mol%), AgOAc (66.8 mg, 0.4 mmol, 2 equiv.), 2-hydroxypyridine (3.8 mg, 0.04 mmol. , 20 mol%), then Tf 2 NH (56.2 mg, 0.2 mmol, 1.0 equiv) was added in the glove box, and finally DCM (1.6 mL), HFIP (0.4 mL), ethyl acrylate (26.1 μL, 0.24 mmol, 1.2 equiv) and o-chlorophenethylamine (0.2 mmol) represented by formula 5-1. The system was reacted at 90 °C for 12 h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. The resulting product sample was designated 5-3, a total of 40.5 mg, and a yield of 80%.
产物样品5-3的检测数据如下:The detection data of product sample 5-3 are as follows:
1H NMR(400MHz,CDCl3)δ7.24(d,J=7.6Hz,1H),7.10(t,J=7.6Hz,1H),7.02(d,J=7.6Hz,1H),4.45(dd,J=9.6,3.6Hz,1H),4.18(q,J=7.2Hz,2H),3.23(dt,J=12.4,6.0Hz,1H),3.05(dt,J=12.4,6.0Hz,1H),2.85–2.72(m,4H),2.08(s,1H),1.27(t,J=7.2Hz,3H).13C NMR(151MHz,CDCl3)δ172.2,140.1,134.9,133.7,127.3,126.7,124.5,60.8,52.8,41.1,40.1,27.7,14.30.HRMS Calcd for C13H17ClNO2[M+H]+254.0942,found254.0942. 1 H NMR (400 MHz, CDCl 3 ) δ 7.24 (d, J=7.6 Hz, 1H), 7.10 (t, J=7.6 Hz, 1H), 7.02 (d, J=7.6 Hz, 1H), 4.45 (dd , J=9.6, 3.6Hz, 1H), 4.18 (q, J=7.2Hz, 2H), 3.23 (dt, J=12.4, 6.0Hz, 1H), 3.05 (dt, J=12.4, 6.0Hz, 1H) , 2.85–2.72(m, 4H), 2.08(s, 1H), 1.27(t, J=7.2Hz, 3H). 13 C NMR(151MHz, CDCl 3 )δ172.2,140.1,134.9,133.7,127.3,126.7, 124.5, 60.8, 52.8, 41.1, 40.1, 27.7, 14.30. HRMS Calcd for C 13 H 17 ClNO 2 [M+H] + 254.0942, found254.0942.
实施例6Example 6
在空气下,往干燥的38mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,10mol%),AgOAc(66.8mg,0.4mmol,2equiv.),2-羟基吡啶(3.8mg,0.04mmol,20mol%),再在手套箱中加入Tf2NH(56.2mg,0.2mmol,1.0equiv),最后依次加入DCM(1.6mL),HFIP(0.4mL),丙烯酸乙酯(26.1μL,0.24mmol,1.2equiv)和式6-1所示邻溴苯乙胺(0.2mmol)。体系在90℃下反应12h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品记为6-3,共51.7mg,产率为87%。Under air, into a dry 38 mL sealed tube was added Pd(OAc) 2 (4.5 mg, 0.02 mmol, 10 mol%), AgOAc (66.8 mg, 0.4 mmol, 2 equiv.), 2-hydroxypyridine (3.8 mg, 0.04 mmol. , 20 mol%), then Tf 2 NH (56.2 mg, 0.2 mmol, 1.0 equiv) was added in the glove box, and finally DCM (1.6 mL), HFIP (0.4 mL), ethyl acrylate (26.1 μL, 0.24 mmol, 1.2equiv) and o-bromophenethylamine represented by formula 6-1 (0.2mmol). The system was reacted at 90 °C for 12 h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. The resulting product sample was designated as 6-3, a total of 51.7 mg, and a yield of 87%.
产物样品6-3的检测数据如下:The detection data of product sample 6-3 are as follows:
1H NMR(400MHz,CDCl3)δ7.43(d,J=7.2Hz,1H),7.08–7.01(m,2H),4.45(dd,J=9.2,4.0Hz,1H),4.18(q,J=7.2Hz,2H),3.23(dt,J=12.4,6.0Hz,1H),3.05(dt,J=12.4,6.0Hz,1H),2.85–2.72(m,4H),2.25(s,1H),1.27(t,J=7.2Hz,3H).13C NMR(101MHz,CDCl3)δ172.1,140.3,135.1,130.5,127.1,126.0,125.1,60.7,52.9,41.0,40.2,30.5,14.2.HRMSCalcd for C13H17BrNO2[M+H]+298.0437,found 298.0438. 1 H NMR (400 MHz, CDCl 3 ) δ 7.43 (d, J=7.2 Hz, 1H), 7.08-7.01 (m, 2H), 4.45 (dd, J=9.2, 4.0 Hz, 1H), 4.18 (q, J=7.2Hz, 2H), 3.23(dt, J=12.4, 6.0Hz, 1H), 3.05(dt, J=12.4, 6.0Hz, 1H), 2.85–2.72(m, 4H), 2.25(s, 1H) ), 1.27 (t, J=7.2Hz, 3H). 13 C NMR (101MHz, CDCl 3 )δ172.1, 140.3, 135.1, 130.5, 127.1, 126.0, 125.1, 60.7, 52.9, 41.0, 40.2, 30.5, 14.2.HRMSCalcd for C 13 H 17 BrNO 2 [M+H] + 298.0437, found 298.0438.
实施例7Example 7
在空气下,往干燥的38mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,10mol%),AgOAc(66.8mg,0.4mmol,2equiv.),2-羟基吡啶(3.8mg,0.04mmol,20mol%),再在手套箱中加入Tf2NH(56.2mg,0.2mmol,1.0equiv),最后依次加入DCM(1.6mL),HFIP(0.4mL),丙烯酸乙酯(26.1μL,0.24mmol,1.2equiv)和式7-1所示的邻三氟甲基苯乙胺(0.2mmol)。体系在90℃下反应12h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品记为7-3,共41.4mg,产率为72%。Under air, into a dry 38 mL sealed tube was added Pd(OAc) 2 (4.5 mg, 0.02 mmol, 10 mol%), AgOAc (66.8 mg, 0.4 mmol, 2 equiv.), 2-hydroxypyridine (3.8 mg, 0.04 mmol. , 20 mol%), then Tf 2 NH (56.2 mg, 0.2 mmol, 1.0 equiv) was added in the glove box, and finally DCM (1.6 mL), HFIP (0.4 mL), ethyl acrylate (26.1 μL, 0.24 mmol, 1.2 equiv) and o-trifluoromethylphenethylamine of formula 7-1 (0.2 mmol). The system was reacted at 90 °C for 12 h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. The resulting product sample was designated as 7-3, a total of 41.4 mg, and a yield of 72%.
产物样品7-3的检测数据如下:The detection data of product sample 7-3 are as follows:
1H NMR(400MHz,CDCl3)δ7.51(d,J=7.2Hz,1H),7.29(d,J=7.2Hz,1H),7.24(t,J=7.6Hz,1H),4.54(dd,J=8.0,4.8Hz,1H),4.18(q,J=7.2Hz,2H),3.25–3.19(m,1H),3.07–3.01(m,1H),3.00–2.96(m,2H),2.85–2.76(m,2H),2.48(s,1H),1.26(t,J=7.2Hz,3H).13C NMR(151MHz,CDCl3)δ172.0,139.2,134.5,130.0,129.1(q,J=29.4Hz),125.7,124.5(q,J=274.4Hz),124.4(q,J=5.8Hz),60.8,53.0,41.4,39.8,26.4,14.3.HRMSCalcd for C14H17F3NO2[M+H]+288.1206,found 288.1207. 1 H NMR (400 MHz, CDCl 3 ) δ 7.51 (d, J=7.2 Hz, 1H), 7.29 (d, J=7.2 Hz, 1H), 7.24 (t, J=7.6 Hz, 1H), 4.54 (dd , J=8.0, 4.8Hz, 1H), 4.18 (q, J=7.2Hz, 2H), 3.25–3.19 (m, 1H), 3.07–3.01 (m, 1H), 3.00–2.96 (m, 2H), 2.85-2.76(m, 2H), 2.48(s, 1H), 1.26(t, J=7.2Hz, 3H). 13 C NMR (151MHz, CDCl 3 ) δ 172.0, 139.2, 134.5, 130.0, 129.1(q, J = 29.4Hz), 125.7, 124.5 (q, J = 274.4 Hz), 124.4 (q, J = 5.8 Hz), 60.8, 53.0, 41.4, 39.8, 26.4, 14.3. HRMSCalcd for C 14 H 17 F 3 NO 2 [ M+H] + 288.1206, found 288.1207.
实施例8Example 8
在空气下,往干燥的38mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,10mol%),AgOAc(100.1mg,0.6mmol,3equiv.),2-羟基吡啶(3.8mg,0.04mmol,20mol%),再在手套箱中加入Tf2NH(56.2mg,0.2mmol,1.0equiv),最后依次加入DCM(1.6mL),HFIP(0.4mL),丙烯酸乙酯(32.6μL,0.3mmol,1.5equiv)和式8-1所示的间甲基苯乙胺(0.2mmol)。体系在90℃下反应24h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品记为8-3,共28.9mg,产率为62%。Under air, into a dry 38 mL sealed tube was added Pd(OAc) 2 (4.5 mg, 0.02 mmol, 10 mol%), AgOAc (100.1 mg, 0.6 mmol, 3 equiv.), 2-hydroxypyridine (3.8 mg, 0.04 mmol. , 20 mol%), then Tf 2 NH (56.2 mg, 0.2 mmol, 1.0 equiv) was added in the glove box, and finally DCM (1.6 mL), HFIP (0.4 mL), ethyl acrylate (32.6 μL, 0.3 mmol, 1.5 equiv) and m-methylphenethylamine of formula 8-1 (0.2 mmol). The system was reacted at 90°C for 24h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. The resulting product sample was designated 8-3, a total of 28.9 mg, and a yield of 62%.
产物样品8-3的检测数据如下:The detection data of product sample 8-3 are as follows:
1H NMR(600MHz,CDCl3)δ6.98–6.94(m,2H),6.91(s,1H),4.43(dd,J=9.6,2.4Hz,1H),4.16(q,J=7.2Hz,2H),3.19(dt,J=12.6,5.4Hz,1H),3.00(ddd,J=12.6,7.8,4.8Hz,1H),2.84(dd,J=16.2,3.6Hz,1H),2.81–2.79(m,1H),2.74–2.69(m,2H),2.50(s,1H),2.28(s,3H),1.25(t,J=7.2Hz,3H).13C NMR(151MHz,CDCl3)δ172.5,136.0,135.3,134.4,130.1,126.9,125.9,60.7,52.6,41.3,40.8,29.7,21.0,14.3.HRMS Calcd for C14H20NO2[M+H]+234.1489,found 234.1490. 1 H NMR (600MHz, CDCl 3 ) δ 6.98-6.94 (m, 2H), 6.91 (s, 1H), 4.43 (dd, J=9.6, 2.4Hz, 1H), 4.16 (q, J=7.2Hz, 2H), 3.19 (dt, J=12.6, 5.4Hz, 1H), 3.00 (ddd, J=12.6, 7.8, 4.8Hz, 1H), 2.84 (dd, J=16.2, 3.6Hz, 1H), 2.81–2.79 (m, 1H), 2.74–2.69 (m, 2H), 2.50 (s, 1H), 2.28 (s, 3H), 1.25 (t, J=7.2Hz, 3H). 13 C NMR (151 MHz, CDCl 3 ) δ172.5,136.0,135.3,134.4,130.1,126.9,125.9,60.7,52.6,41.3,40.8,29.7,21.0,14.3.HRMS Calcd for C 14 H 20 NO 2 [M+H] + 234.1489,found 234.1490.
实施例9Example 9
在空气下,往干燥的38mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,10mol%),AgOAc(66.8mg,0.4mmol,2equiv.),2-羟基吡啶(3.8mg,0.04mmol,20mol%),再在手套箱中加入Tf2NH(56.2mg,0.2mmol,1.0equiv),最后依次加入DCM(1.6mL),HFIP(0.4mL),丙烯酸乙酯(26.1μL,0.24mmol,1.2equiv)和式9-1所示的间三氟甲基苯乙胺(0.2mmol)。体系在90℃下反应24h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品记为9-3。9-3共39mg,产率为68%。Under air, into a dry 38 mL sealed tube was added Pd(OAc) 2 (4.5 mg, 0.02 mmol, 10 mol%), AgOAc (66.8 mg, 0.4 mmol, 2 equiv.), 2-hydroxypyridine (3.8 mg, 0.04 mmol. , 20 mol%), then Tf 2 NH (56.2 mg, 0.2 mmol, 1.0 equiv) was added in the glove box, and finally DCM (1.6 mL), HFIP (0.4 mL), ethyl acrylate (26.1 μL, 0.24 mmol, 1.2 equiv) and m-trifluoromethylphenethylamine of formula 9-1 (0.2 mmol). The system was reacted at 90°C for 24h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. A sample of the obtained product was designated as 9-3. A total of 39 mg of 9-3 was obtained, and the yield was 68%.
产物样品9-3的检测数据如下:The detection data of product sample 9-3 are as follows:
1H NMR(400MHz,CDCl3)δ7.40–7.36(m,2H),7.21(d,J=8.0Hz,1H),4.50(d,J=7.6Hz,1H),4.18(q,J=7.2Hz,2H),3.23(dt,J=12.0,5.6Hz,1H),3.04(ddd,J=12.4,7.2,5.2Hz,1H),2.97–2.73(m,4H),2.23(s,1H),1.27(t,J=7.2Hz,3H).13C NMR(151MHz,CDCl3)δ172.0,141.5,136.4,128.7(q,J=32.5Hz),126.5,126.0(t,J=272.6Hz),124.2(q,J=272.0Hz),122.8(d,J=3.6Hz),60.9,52.7,41.0,40.4,29.8,14.3.HRMS Calcd forC14H17F3NO2[M+H]+288.1206,found 288.1206. 1 H NMR (400 MHz, CDCl 3 ) δ 7.40-7.36 (m, 2H), 7.21 (d, J=8.0 Hz, 1H), 4.50 (d, J=7.6 Hz, 1H), 4.18 (q, J= 7.2Hz, 2H), 3.23 (dt, J=12.0, 5.6Hz, 1H), 3.04 (ddd, J=12.4, 7.2, 5.2Hz, 1H), 2.97–2.73 (m, 4H), 2.23 (s, 1H) ), 1.27 (t, J=7.2Hz, 3H). 13 C NMR (151MHz, CDCl 3 )δ172.0, 141.5, 136.4, 128.7 (q, J=32.5Hz), 126.5, 126.0 (t, J=272.6Hz) ,124.2(q,J=272.0Hz),122.8(d,J=3.6Hz),60.9,52.7,41.0,40.4,29.8,14.3.HRMS Calcd forC 14 H 17 F 3 NO 2 [M+H] + 288.1206 ,found 288.1206.
实施例10Example 10
在空气下,往干燥的38mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,10mol%),AgOAc(100.1mg,0.6mmol,3equiv.),2-羟基吡啶(3.8mg,0.04mmol,20mol%),再在手套箱中加入Tf2NH(56.2mg,0.2mmol,1.0equiv),最后依次加入DCM(1.6mL),HFIP(0.4mL),丙烯酸乙酯(32.6μL,0.3mmol,1.5equiv)和式10-1所示的对甲基苯乙胺(0.2mmol)。体系在90℃下反应24h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品分别记为10-3,10-4。10-3共15.4mg,产率为33%,10-4共33.1mg,产率为50%。Under air, into a dry 38 mL sealed tube was added Pd(OAc) 2 (4.5 mg, 0.02 mmol, 10 mol%), AgOAc (100.1 mg, 0.6 mmol, 3 equiv.), 2-hydroxypyridine (3.8 mg, 0.04 mmol. , 20 mol%), then Tf 2 NH (56.2 mg, 0.2 mmol, 1.0 equiv) was added in the glove box, and finally DCM (1.6 mL), HFIP (0.4 mL), ethyl acrylate (32.6 μL, 0.3 mmol, 1.5 equiv) and p-methylphenethylamine of formula 10-1 (0.2 mmol). The system was reacted at 90 °C for 24 h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. The obtained product samples were recorded as 10-3 and 10-4, respectively. The total of 10-3 was 15.4 mg with a yield of 33%, and the total of 10-4 was 33.1 mg with a yield of 50%.
产物样品10-3的检测数据如下:The detection data of product sample 10-3 are as follows:
1H NMR(400MHz,CDCl3)δ6.98(q,J=8.0Hz,2H),6.91(s,1H),4.45(dd,J=9.6,2.8Hz,1H),4.18(q,J=7.2Hz,2H),3.20(td,J=12.4,5.6Hz,1H),3.02(ddd,J=12.4,7.2,5.2Hz,1H),2.88(dd,J=16.0,3.2Hz,1H),2.84–2.69(m,3H),2.55(s,1H),2.30(s,3H),1.27(t,J=7.2Hz,3H).13C NMR(151MHz,CDCl3)δ172.5,137.2,135.5,132.3,129.4,127.4,126.5,60.7,52.7,41.3,40.8,29.3,21.2,14.3.HRMS Calcd for C14H20NO2[M+H]+234.1489,found 234.1490. 1 H NMR (400 MHz, CDCl 3 ) δ 6.98 (q, J=8.0 Hz, 2H), 6.91 (s, 1H), 4.45 (dd, J=9.6, 2.8 Hz, 1H), 4.18 (q, J= 7.2Hz, 2H), 3.20 (td, J=12.4, 5.6Hz, 1H), 3.02 (ddd, J=12.4, 7.2, 5.2Hz, 1H), 2.88 (dd, J=16.0, 3.2Hz, 1H), 2.84–2.69(m, 3H), 2.55(s, 1H), 2.30(s, 3H), 1.27(t, J=7.2Hz, 3H). 13 C NMR (151MHz, CDCl 3 )δ172.5, 137.2, 135.5, 132.3,129.4,127.4,126.5,60.7,52.7,41.3,40.8,29.3,21.2,14.3.HRMS Calcd for C 14 H 20 NO 2 [M+H] + 234.1489,found 234.1490.
产物样品10-4的检测数据如下:The detection data of product sample 10-4 are as follows:
1H NMR(400MHz,CDCl3)δ7.91(d,J=15.6Hz,1H),7.26(s,1H),6.96(s,1H),6.34(d,J=15.6Hz,1H),4.46(dd,J=9.2,3.2Hz,1H),4.26(q,J=7.2Hz,2H),4.19(q,J=7.2Hz,2H),3.24(td,J=12.8,6.4Hz,1H),3.05(td,J=12.4,6.4Hz,1H),2.91–2.74(m,4H),2.31(s,3H),2.09(s,1H),1.34(t,J=7.2Hz,3H),1.27(t,J=7.2Hz,3H).13C NMR(151MHz,CDCl3)δ172.3,167.1,141.8,138.1,135.5,133.8,131.9,128.7,125.7,120.0,60.8,60.6,52.9,41.2,40.21,26.71,21.2,14.4,14.3.HRMS Calcd for C19H26NO4[M+H]+332.1856,found 332.1854. 1 H NMR (400 MHz, CDCl 3 ) δ 7.91 (d, J=15.6 Hz, 1H), 7.26 (s, 1H), 6.96 (s, 1H), 6.34 (d, J=15.6 Hz, 1H), 4.46 (dd, J=9.2, 3.2Hz, 1H), 4.26 (q, J=7.2Hz, 2H), 4.19 (q, J=7.2Hz, 2H), 3.24 (td, J=12.8, 6.4Hz, 1H) ,3.05(td,J=12.4,6.4Hz,1H),2.91–2.74(m,4H),2.31(s,3H),2.09(s,1H),1.34(t,J=7.2Hz,3H), 1.27 (t, J=7.2Hz, 3H). 13 C NMR (151MHz, CDCl 3 ) δ 172.3, 167.1, 141.8, 138.1, 135.5, 133.8, 131.9, 128.7, 125.7, 120.0, 60.8, 60.6, 52.9, 41.2, 40.21 , 26.71, 21.2, 14.4, 14.3. HRMS Calcd for C 19 H 26 NO 4 [M+H] + 332.1856, found 332.1854.
实施例11Example 11
在空气下,往干燥的38mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,10mol%),AgOAc(100.1mg,0.6mmol,3equiv.),2-羟基吡啶(3.8mg,0.04mmol,20mol%),再在手套箱中加入Tf2NH(56.2mg,0.2mmol,1.0equiv),最后依次加入DCM(1.6mL),HFIP(0.4mL),丙烯酸乙酯(32.6μL,0.3mmol,1.5equiv)和式11-1所示的对甲氧基苯乙胺(0.2mmol)。体系在90℃下反应24h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品分别记为11-3,11-4。11-3共21.4mg,产率为43%,11-4共26.4mg,产率为38%。Under air, into a dry 38 mL sealed tube was added Pd(OAc) 2 (4.5 mg, 0.02 mmol, 10 mol%), AgOAc (100.1 mg, 0.6 mmol, 3 equiv.), 2-hydroxypyridine (3.8 mg, 0.04 mmol. , 20 mol%), then Tf 2 NH (56.2 mg, 0.2 mmol, 1.0 equiv) was added in the glove box, and finally DCM (1.6 mL), HFIP (0.4 mL), ethyl acrylate (32.6 μL, 0.3 mmol, 1.5 equiv) and p-methoxyphenethylamine of formula 11-1 (0.2 mmol). The system was reacted at 90°C for 24h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. The obtained product samples were recorded as 11-3 and 11-4, respectively. The total of 11-3 was 21.4 mg with a yield of 43%, and the total of 11-4 was 26.4 mg with a yield of 38%.
产物样品11-3的检测数据如下:The detection data of product sample 11-3 are as follows:
1H NMR(400MHz,CDCl3)δ7.02(d,J=8.4Hz,1H),6.73(dd,J=8.4,2.4Hz,1H),6.63(d,J=2.4Hz,1H),4.43(dd,J=9.6,3.2Hz,1H),4.18(q,J=7.2Hz,2H),3.77(s,3H),3.19(td,J=12.8,5.6Hz,1H),3.00(ddd,J=12.4,7.2,5.2Hz,1H),2.85(dd,J=16.0,3.6Hz,1H),2.81–2.64(m,3H),2.28(s,1H),1.27(t,J=7.2Hz,3H).13C NMR(151MHz,CDCl3)δ172.4,157.8,138.6,130.4,127.5,112.6,111.1,60.7,55.4,53.0,41.4,40.9,29.0,14.3. 1 H NMR (400MHz, CDCl 3 ) δ 7.02 (d, J=8.4Hz, 1H), 6.73 (dd, J=8.4, 2.4Hz, 1H), 6.63 (d, J=2.4Hz, 1H), 4.43 (dd, J=9.6, 3.2Hz, 1H), 4.18 (q, J=7.2Hz, 2H), 3.77 (s, 3H), 3.19 (td, J=12.8, 5.6Hz, 1H), 3.00 (ddd, J=12.4,7.2,5.2Hz,1H),2.85(dd,J=16.0,3.6Hz,1H),2.81–2.64(m,3H),2.28(s,1H),1.27(t,J=7.2Hz , 3H). 13 C NMR (151MHz, CDCl 3 )δ172.4, 157.8, 138.6, 130.4, 127.5, 112.6, 111.1, 60.7, 55.4, 53.0, 41.4, 40.9, 29.0, 14.3.
产物样品11-4的检测数据如下:The detection data of product sample 11-4 are as follows:
1H NMR(400MHz,CDCl3)δ7.91(d,J=15.6Hz,1H),6.97(d,J=2.4Hz,1H),6.70(d,J=2.0Hz,1H),6.33(d,J=15.6Hz,1H),4.46(dd,J=8.8,4.0Hz,1H),4.27(q,J=7.2Hz,2H),4.19(q,J=7.2Hz,2H),3.80(s,3H),3.24(td,J=12.0,5.6Hz,1H),3.04(td,J=12.4,6.0Hz,1H),2.89–2.75(m,4H),2.31(s,1H),1.34(t,J=7.2Hz,3H),1.27(t,J=7.2Hz,3H).13C NMR(151MHz,CDCl3)δ168.5,163.2,153.9,138.0,135.9,131.3,123.6,116.7,110.1,106.5,57.2,57.0,51.7,49.5,37.5,36.6,22.8,10.7,10.6.HRMS Calcd for C19H26NO5[M+H]+348.1805,found 348.1805. 1 H NMR (400 MHz, CDCl 3 ) δ 7.91 (d, J=15.6 Hz, 1H), 6.97 (d, J=2.4 Hz, 1H), 6.70 (d, J=2.0 Hz, 1H), 6.33 (d , J=15.6Hz, 1H), 4.46(dd, J=8.8, 4.0Hz, 1H), 4.27(q, J=7.2Hz, 2H), 4.19(q, J=7.2Hz, 2H), 3.80(s ,3H),3.24(td,J=12.0,5.6Hz,1H),3.04(td,J=12.4,6.0Hz,1H),2.89–2.75(m,4H),2.31(s,1H),1.34( t, J=7.2Hz, 3H), 1.27 (t, J=7.2Hz, 3H). 13 C NMR (151MHz, CDCl 3 ) δ 168.5, 163.2, 153.9, 138.0, 135.9, 131.3, 123.6, 116.7, 110.1, 106.5 ,57.2,57.0,51.7,49.5,37.5,36.6,22.8,10.7,10.6.HRMS Calcd for C 19 H 26 NO 5 [M+H] + 348.1805,found 348.1805.
实施例12Example 12
在空气下,往干燥的38mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,10mol%),AgOAc(100.1mg,0.6mmol,3equiv.),2-羟基吡啶(3.8mg,0.04mmol,20mol%),再在手套箱中加入Tf2NH(56.2mg,0.2mmol,1.0equiv),最后依次加入DCM(1.6mL),HFIP(0.4mL),丙烯酸乙酯(32.6μL,0.3mmol,1.5equiv)和式12-1所示的对氟苯乙胺(0.2mmol)。体系在90℃下反应24h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品分别记为12-3,12-4。12-3共19mg,产率为40%,12-4共17.4mg,产率为26%。Under air, into a dry 38 mL sealed tube was added Pd(OAc) 2 (4.5 mg, 0.02 mmol, 10 mol%), AgOAc (100.1 mg, 0.6 mmol, 3 equiv.), 2-hydroxypyridine (3.8 mg, 0.04 mmol. , 20 mol%), then Tf 2 NH (56.2 mg, 0.2 mmol, 1.0 equiv) was added in the glove box, and finally DCM (1.6 mL), HFIP (0.4 mL), ethyl acrylate (32.6 μL, 0.3 mmol, 1.5 equiv) and p-fluorophenethylamine of formula 12-1 (0.2 mmol). The system was reacted at 90°C for 24h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. The obtained product samples were recorded as 12-3 and 12-4, respectively. The total yield of 12-3 was 19 mg with a yield of 40%, and the yield of 12-4 was 17.4 mg with a yield of 26%.
产物样品12-3的检测数据如下:The detection data of product sample 12-3 are as follows:
1H NMR(400MHz,CDCl3)δ7.06(dd,J=8.0,6.0Hz,1H),6.86(td,J=8.4,2.4Hz,1H),6.80(dd,J=10.0,2.4Hz,1H),4.43(dd,J=9.2,2.8Hz,1H),4.18(q,J=7.2Hz,2H),3.20(td,J=11.2,5.6Hz,1H),3.01(ddd,J=12.4,7.2,4.8Hz,1H),2.86–2.69(m,4H),2.27(s,1H),1.27(t,J=7.2Hz,3H).13C NMR(101MHz,CDCl3)δ172.1,161.0(d,J=244.5Hz),139.2(d,J=6.4Hz),130.9(d,J=3.0Hz),130.8(d,J=7.8Hz),113.6(d,J=2.1Hz),112.3(d,J=2.2Hz),60.8,52.7,41.0,40.8,29.0,14.2.HRMS Calcd for C13H17FNO2[M+H]+238.1238,found 238.1238. 1 H NMR (400 MHz, CDCl 3 ) δ 7.06 (dd, J=8.0, 6.0 Hz, 1H), 6.86 (td, J=8.4, 2.4 Hz, 1H), 6.80 (dd, J=10.0, 2.4 Hz, 1H), 4.43 (dd, J=9.2, 2.8Hz, 1H), 4.18 (q, J=7.2Hz, 2H), 3.20 (td, J=11.2, 5.6Hz, 1H), 3.01 (ddd, J=12.4 , 7.2, 4.8Hz, 1H), 2.86-2.69(m, 4H), 2.27(s, 1H), 1.27(t, J=7.2Hz, 3H). 13 C NMR(101MHz, CDCl 3 )δ172.1,161.0( d, J=244.5Hz), 139.2 (d, J=6.4Hz), 130.9 (d, J=3.0Hz), 130.8 (d, J=7.8Hz), 113.6 (d, J=2.1Hz), 112.3 ( d, J=2.2Hz), 60.8, 52.7, 41.0, 40.8, 29.0, 14.2. HRMS Calcd for C 13 H 17 FNO 2 [M+H] + 238.1238, found 238.1238.
产物样品12-4的检测数据如下:The detection data of product sample 12-4 are as follows:
1H NMR(400MHz,CDCl3)δ7.88(d,J=16.0Hz,1H),7.13(dd,J=9.6,2.4Hz,1H),6.86(dd,J=9.6,2.4Hz,1H),6.32(d,J=15.6Hz,1H),4.46(dd,J=8.4,4.4Hz,1H),4.27(q,J=7.2Hz,2H),4.19(q,J=7.2Hz,2H),3.26(dt,J=12.4,6.0Hz,1H),3.05(dt,J=12.4,6.0Hz,1H),2.86–2.75(m,4H),2.39(s,1H),1.34(t,J=7.2Hz,3H),1.27(t,J=7.2Hz,3H).13C NMR(151MHz,CDCl3)δ171.9,166.6,160.9(d,J=244.8Hz),140.5(d,J=2.0Hz),140.4(d,J=6.2Hz),135.9(d,J=7.4Hz),130.5(d,J=2.7Hz),121.4,114.4(d,J=21.7Hz),111.7(d,J=22.2Hz),61.0,60.8,53.0,40.8,40.3,26.6,14.4,14.3.HRMSCalcd for C18H23FNO4[M+H]+336.1606,found 336.1608. 1 H NMR (400 MHz, CDCl 3 ) δ 7.88 (d, J=16.0 Hz, 1H), 7.13 (dd, J=9.6, 2.4 Hz, 1H), 6.86 (dd, J=9.6, 2.4 Hz, 1H) ,6.32(d,J=15.6Hz,1H),4.46(dd,J=8.4,4.4Hz,1H),4.27(q,J=7.2Hz,2H),4.19(q,J=7.2Hz,2H) ,3.26(dt,J=12.4,6.0Hz,1H),3.05(dt,J=12.4,6.0Hz,1H),2.86–2.75(m,4H),2.39(s,1H),1.34(t,J =7.2Hz, 3H), 1.27(t, J=7.2Hz, 3H). 13 C NMR (151MHz, CDCl 3 ) δ 171.9, 166.6, 160.9 (d, J=244.8Hz), 140.5 (d, J=2.0Hz) ), 140.4(d, J=6.2Hz), 135.9(d, J=7.4Hz), 130.5(d, J=2.7Hz), 121.4, 114.4(d, J=21.7Hz), 111.7(d, J= 22.2Hz), 61.0, 60.8, 53.0, 40.8, 40.3, 26.6, 14.4, 14.3. HRMSCalcd for C 18 H 23 FNO 4 [M+H] + 336.1606, found 336.1608.
实施例13Example 13
在空气下,往干燥的38mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,10mol%),AgOAc(66.8mg,0.4mmol,2equiv.),2-羟基吡啶(3.8mg,0.04mmol,20mol%),再在手套箱中加入Tf2NH(56.2mg,0.2mmol,1.0equiv),最后依次加入DCM(1.6mL),HFIP(0.4mL),丙烯酸乙酯(26.1μL,0.24mmol,1.2equiv)和式13-1所示的对溴苯乙胺(0.2mmol)。体系在90℃下反应12h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品记为13-3。13-3共30.9mg,产率为52%。Under air, into a dry 38 mL sealed tube was added Pd(OAc) 2 (4.5 mg, 0.02 mmol, 10 mol%), AgOAc (66.8 mg, 0.4 mmol, 2 equiv.), 2-hydroxypyridine (3.8 mg, 0.04 mmol. , 20 mol%), then Tf 2 NH (56.2 mg, 0.2 mmol, 1.0 equiv) was added in the glove box, and finally DCM (1.6 mL), HFIP (0.4 mL), ethyl acrylate (26.1 μL, 0.24 mmol, 1.2 equiv) and p-bromophenethylamine of formula 13-1 (0.2 mmol). The system was reacted at 90 °C for 12 h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. A sample of the obtained product was designated as 13-3. A total of 30.9 mg of 13-3 was obtained, and the yield was 52%.
产物样品13-3的检测数据如下:The detection data of product sample 13-3 are as follows:
1H NMR(400MHz,CDCl3)δ7.27–7.24(m,2H),6.98(d,J=8.4Hz,1H),4.43(dd,J=9.6,3.2Hz,1H),4.18(q,J=7.2Hz,2H),3.20(td,J=12.4,5.6Hz,1H),3.01(ddd,J=12.4,7.2,5.2Hz,1H),2.85(dd,J=16.0,3.6Hz,1H),2.79–2.67(m,3H),2.29(s,1H),1.27(t,J=7.2Hz,3H).13C NMR(151MHz,CDCl3)δ172.1,139.6,134.4,131.2,129.6,128.9,119.5,60.9,52.5,41.1,40.5,29.2,14.3.HRMS Calcd for C13H17BrNO2[M+H]+298.0437,found298.0435. 1 H NMR (400MHz, CDCl 3 ) δ 7.27-7.24 (m, 2H), 6.98 (d, J=8.4Hz, 1H), 4.43 (dd, J=9.6, 3.2Hz, 1H), 4.18 (q, J=7.2Hz, 2H), 3.20 (td, J=12.4, 5.6Hz, 1H), 3.01 (ddd, J=12.4, 7.2, 5.2Hz, 1H), 2.85 (dd, J=16.0, 3.6Hz, 1H) The _ ,119.5,60.9,52.5,41.1,40.5,29.2,14.3.HRMS Calcd for C 13 H 17 BrNO 2 [M+H] + 298.0437,found298.0435.
实施例14Example 14
在空气下,往干燥的38mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,10mol%),AgOAc(66.8mg,0.4mmol,2equiv.),2-羟基吡啶(3.8mg,0.04mmol,20mol%),再在手套箱中加入Tf2NH(56.2mg,0.2mmol,1.0equiv),最后依次加入DCM(1.6mL),HFIP(0.4mL),丙烯酸乙酯(26.1μL,0.24mmol,1.2equiv)和式14-1所示的对三氟甲基苯乙胺(0.2mmol)。体系在90℃下反应12h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品分别记为14-3,14-4。14-3共38.5mg,产率为67%,14-4共10.0mg,产率为13%。Under air, into a dry 38 mL sealed tube was added Pd(OAc) 2 (4.5 mg, 0.02 mmol, 10 mol%), AgOAc (66.8 mg, 0.4 mmol, 2 equiv.), 2-hydroxypyridine (3.8 mg, 0.04 mmol. , 20 mol%), then Tf 2 NH (56.2 mg, 0.2 mmol, 1.0 equiv) was added in the glove box, and finally DCM (1.6 mL), HFIP (0.4 mL), ethyl acrylate (26.1 μL, 0.24 mmol, 1.2 equiv) and p-trifluoromethylphenethylamine of formula 14-1 (0.2 mmol). The system was reacted at 90 °C for 12 h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. The obtained product samples were recorded as 14-3 and 14-4, respectively. The total of 14-3 was 38.5 mg with a yield of 67%, and the total of 14-4 was 10.0 mg with a yield of 13%.
产物样品14-3的检测数据如下:The detection data of product sample 14-3 are as follows:
1H NMR(400MHz,CDCl3)δ7.39(d,J=8.0Hz,1H),7.35(s,1H),7.22(d,J=8.4Hz,1H),4.50(dd,J=9.6,2.8Hz,1H),4.18(q,J=7.2Hz,2H),3.24(td,J=12.4,6.0Hz,1H),3.05(ddd,J=12.4,7.2,5.2Hz,1H),2.95–2.75(m,4H),2.48(s,1H),1.27(t,J=7.2Hz,3H).13C NMR(151MHz,CDCl3)δ172.0,139.7,138.2,130.1,128.4(q,J=32.3Hz),124.2(q,J=272.25Hz),123.2,122.8,60.9,52.7,41.0,40.4,29.8,14.3.HRMS Calcd forC14H17F3NO2[M+H]+288.1206,found 288.1204. 1 H NMR (400 MHz, CDCl 3 ) δ 7.39 (d, J=8.0 Hz, 1H), 7.35 (s, 1H), 7.22 (d, J=8.4 Hz, 1H), 4.50 (dd, J=9.6, 2.8Hz, 1H), 4.18 (q, J=7.2Hz, 2H), 3.24 (td, J=12.4, 6.0Hz, 1H), 3.05 (ddd, J=12.4, 7.2, 5.2Hz, 1H), 2.95– 2.75(m, 4H), 2.48(s, 1H), 1.27(t, J=7.2Hz, 3H). 13 C NMR (151MHz, CDCl 3 ) δ 172.0, 139.7, 138.2, 130.1, 128.4 (q, J=32.3 Hz), 124.2(q, J=272.25Hz), 123.2, 122.8, 60.9, 52.7, 41.0, 40.4, 29.8, 14.3. HRMS Calcd for C 14 H 17 F 3 NO 2 [M+H] + 288.1206, found 288.1204.
产物样品14-4的检测数据如下:The detection data of product sample 14-4 are as follows:
1H NMR(400MHz,CDCl3)δ7.90(d,J=16.0Hz,1H),7.65(s,1H),7.39(s,1H),6.41(d,J=15.6Hz,1H),4.56(dd,J=8.4,4.0Hz,1H),4.28(q,J=7.2Hz,2H),4.19(q,J=7.2Hz,2H),3.31(td,J=12.8,5.6Hz,1H),3.11(td,J=12.8,6.0Hz,1H),3.00–2.80(m,5H),1.35(t,J=7.2Hz,3H),1.27(t,J=7.2Hz,3H).13C NMR(151MHz,CDCl3)δ171.7,166.5,140.3,139.0,138.5,135.0,128.7(q,J=32.5Hz),125.7(q,J=272.40Hz),124.1(d,J=3.47Hz),122.2,121.7(d,J=3.3Hz),61.1,60.9,52.9,40.8,39.9,27.1,14.4,14.2.HRMSCalcd for C19H23F3NO4[M+H]+386.1574,found 386.1575. 1 H NMR (400 MHz, CDCl 3 ) δ 7.90 (d, J=16.0 Hz, 1H), 7.65 (s, 1H), 7.39 (s, 1H), 6.41 (d, J=15.6 Hz, 1H), 4.56 (dd, J=8.4, 4.0Hz, 1H), 4.28 (q, J=7.2Hz, 2H), 4.19 (q, J=7.2Hz, 2H), 3.31 (td, J=12.8, 5.6Hz, 1H) 13 C NMR (151MHz, CDCl 3 ) δ 171.7, 166.5, 140.3, 139.0, 138.5, 135.0, 128.7 (q, J=32.5 Hz), 125.7 (q, J=272.40 Hz), 124.1 (d, J=3.47 Hz), 122.2 ,121.7(d,J=3.3Hz),61.1,60.9,52.9,40.8,39.9,27.1,14.4,14.2.HRMSCalcd for C 19 H 23 F 3 NO 4 [M+H] + 386.1574,found 386.1575.
实施例15Example 15
在空气下,往干燥的38mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,10mol%),AgOAc(66.8mg,0.4mmol,2equiv.),2-羟基吡啶(3.8mg,0.04mmol,20mol%),再在手套箱中加入Tf2NH(56.2mg,0.2mmol,1.0equiv),最后依次加入DCM(1.6mL),HFIP(0.4mL),丙烯酸乙酯(26.1μL,0.24mmol,1.2equiv)和式15-1所示的2,3-二甲基苯乙胺(0.2mmol)。体系在90℃下反应12h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品记为15-3,共36.6mg,产率为74%。Under air, into a dry 38 mL sealed tube was added Pd(OAc) 2 (4.5 mg, 0.02 mmol, 10 mol%), AgOAc (66.8 mg, 0.4 mmol, 2 equiv.), 2-hydroxypyridine (3.8 mg, 0.04 mmol. , 20 mol%), then Tf 2 NH (56.2 mg, 0.2 mmol, 1.0 equiv) was added in the glove box, and finally DCM (1.6 mL), HFIP (0.4 mL), ethyl acrylate (26.1 μL, 0.24 mmol, 1.2 equiv) and 2,3-dimethylphenethylamine of formula 15-1 (0.2 mmol). The system was reacted at 90 °C for 12 h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. The resulting product sample was designated as 15-3, a total of 36.6 mg, and a yield of 74%.
产物样品15-3的检测数据如下:The detection data of product sample 15-3 are as follows:
1H NMR(400MHz,CDCl3)δ6.98(d,J=8.0Hz,1H),6.87(d,J=8.0Hz,1H),4.45(dd,J=9.6,2.4Hz,1H),4.18(q,J=7.2Hz,2H),3.23(dt,J=12.4,6.0Hz,1H),3.04(dt,J=12.4,6.0Hz,1H),2.85(dd,J=16.0,3.2Hz,1H),2.76–2.66(m,3H),2.34(s,1H),2.26(s,3H),2.13(s,3H),1.27(t,J=7.2Hz,3H).13C NMR(151MHz,CDCl3)δ172.6,135.2,135.1,134.6,133.8,127.4,123.3,60.7,53.1,41.4,40.7,27.8,20.5,14.8,14.3.HRMS Calcdfor C15H22NO2[M+H]+248.1645,found 248.1645. 1 H NMR (400 MHz, CDCl 3 ) δ 6.98 (d, J=8.0 Hz, 1H), 6.87 (d, J=8.0 Hz, 1H), 4.45 (dd, J=9.6, 2.4 Hz, 1H), 4.18 (q, J=7.2Hz, 2H), 3.23 (dt, J=12.4, 6.0Hz, 1H), 3.04 (dt, J=12.4, 6.0Hz, 1H), 2.85 (dd, J=16.0, 3.2Hz, 1H), 2.76–2.66(m, 3H), 2.34(s, 1H), 2.26(s, 3H), 2.13(s, 3H), 1.27(t, J=7.2Hz, 3H). 13 C NMR(151MHz) , CDCl 3 )δ172.6,135.2,135.1,134.6,133.8,127.4,123.3,60.7,53.1,41.4,40.7,27.8,20.5,14.8,14.3.HRMS Calcdfor C 15 H 22 NO 2 [M+H] + 248.1645, found 248.1645.
实施例16Example 16
在空气下,往干燥的38mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,10mol%),AgOAc(66.8mg,0.4mmol,2equiv.),2-羟基吡啶(3.8mg,0.04mmol,20mol%),再在手套箱中加入Tf2NH(56.2mg,0.2mmol,1.0equiv),最后依次加入DCM(1.6mL),HFIP(0.4mL),丙烯酸乙酯(26.1μL,0.24mmol,1.2equiv)和式16-1所示的2,4-二氯苯乙胺(0.2mmol)。体系在90℃下反应12h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品记为16-3,共40.2mg,产率为70%。产物样品16-3的检测数据如下:Under air, into a dry 38 mL sealed tube was added Pd(OAc) 2 (4.5 mg, 0.02 mmol, 10 mol%), AgOAc (66.8 mg, 0.4 mmol, 2 equiv.), 2-hydroxypyridine (3.8 mg, 0.04 mmol. , 20 mol%), then Tf 2 NH (56.2 mg, 0.2 mmol, 1.0 equiv) was added in the glove box, and finally DCM (1.6 mL), HFIP (0.4 mL), ethyl acrylate (26.1 μL, 0.24 mmol, 1.2 equiv) and 2,4-dichlorophenethylamine of formula 16-1 (0.2 mmol). The system was reacted at 90 °C for 12 h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. The resulting product sample was designated as 16-3, a total of 40.2 mg, and a yield of 70%. The detection data of product sample 16-3 are as follows:
1H NMR(400MHz,CDCl3)δ7.25(d,J=2.0Hz,1H),7.03(d,J=1.2Hz,1H),4.40(dd,J=8.8,4.0Hz,1H),4.18(q,J=7.2Hz,2H),3.21(dt,J=12.0,6.0Hz,1H),3.03(dt,J=12.4,6.0Hz,1H),2.83–2.72(m,4H),2.25(s,1H),1.27(t,J=7.2Hz,3H).13C NMR(151MHz,CDCl3)δ171.7,141.3,135.4,132.3,131.6,127.0,124.6,60.8,52.7,40.8,39.9,27.2,14.2.HRMS Calcd for C13H16Cl2NO2[M+H]+288.0553,found 288.0553. 1 H NMR (400 MHz, CDCl 3 ) δ 7.25 (d, J=2.0 Hz, 1H), 7.03 (d, J=1.2 Hz, 1H), 4.40 (dd, J=8.8, 4.0 Hz, 1H), 4.18 (q, J=7.2Hz, 2H), 3.21 (dt, J=12.0, 6.0Hz, 1H), 3.03 (dt, J=12.4, 6.0Hz, 1H), 2.83–2.72 (m, 4H), 2.25 ( s, 1H), 1.27 (t, J=7.2Hz, 3H). 13 C NMR (151MHz, CDCl 3 )δ171.7, 141.3, 135.4, 132.3, 131.6, 127.0, 124.6, 60.8, 52.7, 40.8, 39.9, 27.2, 14.2. HRMS Calcd for C 13 H 16 Cl 2 NO 2 [M+H] + 288.0553, found 288.0553.
实施例17Example 17
在空气下,往干燥的38mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,10mol%),AgOAc(100.1mg,0.6mmol,3equiv.),2-羟基吡啶(3.8mg,0.04mmol,20mol%),再在手套箱中加入Tf2NH(56.2mg,0.2mmol,1.0equiv),最后依次加入DCM(1.6mL),HFIP(0.4mL),丙烯酸乙酯(2.6μL,0.3mmol,1.5equiv)和N-甲基苯乙胺(0.2mmol)。体系在90℃下反应24h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品分别记为17-3,17-4。17-3共20.5mg,产率为44%,17-4共33.1mg,产率为50%。Under air, into a dry 38 mL sealed tube was added Pd(OAc) 2 (4.5 mg, 0.02 mmol, 10 mol%), AgOAc (100.1 mg, 0.6 mmol, 3 equiv.), 2-hydroxypyridine (3.8 mg, 0.04 mmol. , 20 mol%), then Tf 2 NH (56.2 mg, 0.2 mmol, 1.0 equiv) was added in the glove box, and finally DCM (1.6 mL), HFIP (0.4 mL), ethyl acrylate (2.6 μL, 0.3 mmol, 1.5 equiv) and N-methylphenethylamine (0.2 mmol). The system was reacted at 90°C for 24h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. The obtained product samples were recorded as 17-3 and 17-4, respectively. The total of 17-3 was 20.5 mg with a yield of 44%, and the total of 17-4 was 33.1 mg with a yield of 50%.
产物样品17-3的检测数据如下:The detection data of product sample 17-3 are as follows:
1H NMR(400MHz,CDCl3)δ7.22–7.00(m,4H),4.28–4.05(m,3H),3.12(ddd,J=12.8,9.6,4.8Hz,1H),3.01–2.89(m,1H),2.85–2.78(m,2H),2.67(dt,J=16.0,4.0Hz,1H),2.60(dd,J=15.2,5.2Hz,1H),2.49(s,3H),1.25(t,J=7.2Hz,3H).13C NMR(151MHz,CDCl3)δ172.3,137.2,134.1,129.1,127.4,126.5,126.1,60.6,60.0,46.3,42.3,41.0,25.1,14.27.HRMS Calcd for C14H20NO2[M+H]+234.1489,found 234.1489. 1 H NMR (400MHz, CDCl 3 ) δ 7.22-7.00 (m, 4H), 4.28-4.05 (m, 3H), 3.12 (ddd, J=12.8, 9.6, 4.8Hz, 1H), 3.01-2.89 (m ,1H),2.85–2.78(m,2H),2.67(dt,J=16.0,4.0Hz,1H),2.60(dd,J=15.2,5.2Hz,1H),2.49(s,3H),1.25( t, J=7.2Hz, 3H). 13 C NMR (151MHz, CDCl 3 )δ172.3, 137.2, 134.1, 129.1, 127.4, 126.5, 126.1, 60.6, 60.0, 46.3, 42.3, 41.0, 25.1, 14.27. HRMS Calcd for C 14 H 20 NO 2 [M+H] + 234.1489, found 234.1489.
产物样品17-4的检测数据如下:The detection data of product sample 17-4 are as follows:
1H NMR(400MHz,CDCl3)δ7.95(d,J=16.0Hz,1H),7.44(d,J=7.2Hz,1H),7.22–7.07(m,2H),6.35(d,J=16.0Hz,1H),4.27(q,J=7.3Hz,2H),4.17(qd,J=7.2,2.0Hz,3H),3.21–3.07(m,1H),3.03–2.92(m,1H),2.91–2.70(m,3H),2.59(dd,J=15.2,5.6Hz,1H),2.47(s,3H),1.34(t,J=7.2Hz,3H),1.25(t,J=7.2Hz,3H).13C NMR(151MHz,CDCl3)δ172.2,167.0,141.6,138.0,133.5,129.4,126.2,125.0,120.1,60.7,60.1,45.7,42.2,40.6,22.6,14.4,14.3.HRMS Calcd for C19H26NO4[M+H]+332.1856,found 332.1856. 1 H NMR (400 MHz, CDCl 3 ) δ 7.95 (d, J=16.0 Hz, 1H), 7.44 (d, J=7.2 Hz, 1H), 7.22-7.07 (m, 2H), 6.35 (d, J= 16.0Hz, 1H), 4.27 (q, J=7.3Hz, 2H), 4.17 (qd, J=7.2, 2.0Hz, 3H), 3.21–3.07 (m, 1H), 3.03–2.92 (m, 1H), 2.91–2.70(m, 3H), 2.59(dd, J=15.2, 5.6Hz, 1H), 2.47(s, 3H), 1.34(t, J=7.2Hz, 3H), 1.25(t, J=7.2Hz) , 3H). 13 C NMR (151MHz, CDCl 3 )δ172.2,167.0,141.6,138.0,133.5,129.4,126.2,125.0,120.1,60.7,60.1,45.7,42.2,40.6,22.6,14.4,14.3.HRMS Calcd for C 19 H 26 NO 4 [M+H] + 332.1856, found 332.1856.
实施例18Example 18
在空气下,往干燥的38mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,10mol%),AgOAc(66.8mg,0.4mmol,2equiv.),2-羟基吡啶(3.8mg,0.04mmol,20mol%),再在手套箱中加入Tf2NH(56.2mg,0.2mmol,1.0equiv),最后依次加入DCM(1.6mL),HFIP(0.4mL),丙烯酸乙酯(26.1μL,0.24mmol,1.2equiv)和式18-1所示的N-甲基邻甲基苯乙胺(0.2mmol)。体系在90℃下反应12h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品记为18-3,共41.5mg,产率为84%。产物样品18-3的检测数据如下:Under air, into a dry 38 mL sealed tube was added Pd(OAc) 2 (4.5 mg, 0.02 mmol, 10 mol%), AgOAc (66.8 mg, 0.4 mmol, 2 equiv.), 2-hydroxypyridine (3.8 mg, 0.04 mmol. , 20 mol%), then Tf 2 NH (56.2 mg, 0.2 mmol, 1.0 equiv) was added in the glove box, and finally DCM (1.6 mL), HFIP (0.4 mL), ethyl acrylate (26.1 μL, 0.24 mmol, 1.2 equiv) and N-methyl-o-methylphenethylamine of formula 18-1 (0.2 mmol). The system was reacted at 90 °C for 12 h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. The resulting product sample was designated as 18-3, a total of 41.5 mg, and a yield of 84%. The detection data of product sample 18-3 are as follows:
1H NMR(400MHz,CDCl3)δ7.06(t,J=7.2Hz,1H),7.02(d,J=6.4Hz,1H),6.94(d,J=7.6Hz,1H),4.29–4.05(m,3H),3.14(ddd,J=13.2,10.0,5.2Hz,1H),2.91–2.70(m,3H),2.58(dd,J=15.2,5.2Hz,1H),2.52–2.48(m,1H),2.46(s,3H),2.22(s,3H),1.25(t,J=7.2Hz,3H).13C NMR(151MHz,CDCl3)δ172.4,137.0,136.5,132.6,127.9,125.7,125.2,60.5,60.2,45.8,42.1,40.9,22.5,19.3,14.3.HRMS Calcd for C15H22NO2[M+H]+248.1645,found 248.1645. 1 H NMR (400 MHz, CDCl 3 ) δ 7.06 (t, J=7.2 Hz, 1H), 7.02 (d, J=6.4 Hz, 1H), 6.94 (d, J=7.6 Hz, 1H), 4.29-4.05 (m, 3H), 3.14 (ddd, J=13.2, 10.0, 5.2Hz, 1H), 2.91–2.70 (m, 3H), 2.58 (dd, J=15.2, 5.2Hz, 1H), 2.52–2.48 (m , 1H), 2.46(s, 3H), 2.22(s, 3H), 1.25(t, J=7.2Hz, 3H). 13 C NMR (151MHz, CDCl 3 )δ172.4, 137.0, 136.5, 132.6, 127.9, 125.7 ,125.2,60.5,60.2,45.8,42.1,40.9,22.5,19.3,14.3.HRMS Calcd for C 15 H 22 NO 2 [M+H] + 248.1645,found 248.1645.
实施例19Example 19
在空气下,往干燥的38mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,10mol%),AgOAc(66.8mg,0.4mmol,2equiv.),2-羟基吡啶(3.8mg,0.04mmol,20mol%),再在手套箱中加入Tf2NH(56.2mg,0.2mmol,1.0equiv),最后依次加入DCM(1.6mL),HFIP(0.4mL),丙烯酸乙酯(32.6μL,0.3mmol,1.5equiv)和式19-1所示的N-甲基邻甲氧基苯乙胺(0.2mmol)。体系在90℃下反应24h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品记为19-3,共27.4mg,产率为52%。Under air, into a dry 38 mL sealed tube was added Pd(OAc) 2 (4.5 mg, 0.02 mmol, 10 mol%), AgOAc (66.8 mg, 0.4 mmol, 2 equiv.), 2-hydroxypyridine (3.8 mg, 0.04 mmol. , 20 mol%), then Tf 2 NH (56.2 mg, 0.2 mmol, 1.0 equiv) was added in the glove box, and finally DCM (1.6 mL), HFIP (0.4 mL), ethyl acrylate (32.6 μL, 0.3 mmol, 1.5 equiv) and N-methyl-o-methoxyphenethylamine of formula 19-1 (0.2 mmol). The system was reacted at 90°C for 24h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. The resulting product sample was designated as 19-3, a total of 27.4 mg, and a yield of 52%.
产物样品19-3的检测数据如下:The detection data of product sample 19-3 are as follows:
1H NMR(400MHz,CDCl3)δ7.12(t,J=8.0Hz,1H),6.70(t,J=8.0Hz,2H),4.21–4.14(m,3H),3.82(s,3H),3.12–3.05(m,1H),2.87–2.70(m,3H),2.63–2.53(m,2H),2.46(s,3H),1.26(t,J=7.2Hz,3H).13C NMR(101MHz,CDCl3)δ172.2,156.9,138.1,126.3,122.9,119.5,107.5,60.5,59.6,55.3,45.3,42.0,40.7,18.8,14.2.HRMS Calcd for C15H22NO3[M+H]+264.1594,found 264.1595. 1 H NMR (400 MHz, CDCl 3 ) δ 7.12 (t, J=8.0 Hz, 1H), 6.70 (t, J=8.0 Hz, 2H), 4.21-4.14 (m, 3H), 3.82 (s, 3H) 13 C NMR (101MHz, CDCl 3 )δ172.2,156.9,138.1,126.3,122.9,119.5,107.5,60.5,59.6,55.3,45.3,42.0,40.7,18.8,14.2.HRMS Calcd for C 15 H 22 NO 3 [M+H] + 264.1594, found 264.1595.
实施例20Example 20
在空气下,往干燥的38mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,10mol%),AgOAc(66.8mg,0.4mmol,2equiv.),2-羟基吡啶(3.8mg,0.04mmol,20mol%),再在手套箱中加入Tf2NH(56.2mg,0.2mmol,1.0equiv),最后依次加入DCM(1.6mL),HFIP(0.4mL),丙烯酸乙酯(26.1μL,0.24mmol,1.2equiv)和式20-1所示的N-甲基邻溴苯乙胺(0.2mmol)。体系在90℃下反应12h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品记为20-3,共34.8mg,产率为56%。Under air, into a dry 38 mL sealed tube was added Pd(OAc) 2 (4.5 mg, 0.02 mmol, 10 mol%), AgOAc (66.8 mg, 0.4 mmol, 2 equiv.), 2-hydroxypyridine (3.8 mg, 0.04 mmol. , 20 mol%), then Tf 2 NH (56.2 mg, 0.2 mmol, 1.0 equiv) was added in the glove box, and finally DCM (1.6 mL), HFIP (0.4 mL), ethyl acrylate (26.1 μL, 0.24 mmol, 1.2 equiv) and N-methyl-o-bromophenethylamine of formula 20-1 (0.2 mmol). The system was reacted at 90 °C for 12 h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. The resulting product sample was designated as 20-3, a total of 34.8 mg, and a yield of 56%.
产物样品20-3的检测数据如下:The detection data of product sample 20-3 are as follows:
1H NMR(400MHz,CDCl3)δ7.43(d,J=7.6Hz,1H),7.08–7.01(m,2H),4.19–4.14(m,3H),3.16–3.09(m,1H),2.94–2.79(m,3H),2.70–2.63(m,1H),2.56(dd,J=11.2,5.6Hz,1H),2.46(s,3H),1.25(t,J=7.2Hz,3H).13C NMR(151MHz,CDCl3)δ172.0,139.7,133.7,130.7,127.4,126.6,125.6,60.7,59.9,45.6,42.0,40.6,25.7,14.3.HRMS Calcd forC14H19BrNO2[M+H]+312.0594,found 312.0594. 1 H NMR (400 MHz, CDCl 3 ) δ 7.43 (d, J=7.6 Hz, 1H), 7.08–7.01 (m, 2H), 4.19–4.14 (m, 3H), 3.16–3.09 (m, 1H), 2.94–2.79 (m, 3H), 2.70–2.63 (m, 1H), 2.56 (dd, J=11.2, 5.6Hz, 1H), 2.46 (s, 3H), 1.25 (t, J=7.2Hz, 3H) . 13 C NMR (151MHz, CDCl 3 ) δ 172.0, 139.7, 133.7, 130.7, 127.4, 126.6, 125.6, 60.7, 59.9, 45.6, 42.0, 40.6, 25.7, 14.3. HRMS Calcd for C 14 H 19 BrNO 2 [M+H ] + 312.0594, found 312.0594.
实施例21Example 21
在空气下,往干燥的38mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,10mol%),AgOAc(100.1mg,0.6mmol,3equiv.),2-羟基吡啶(3.8mg,0.04mmol,20mol%),再在手套箱中加入Tf2NH(56.2mg,0.2mmol,1.0equiv),最后依次加入DCM(1.6mL),HFIP(0.4mL),丙烯酸乙酯(2.6μL,0.3mmol,1.5equiv)和式21-1所示的N-甲基对甲基苯乙胺(0.2mmol)。体系在90℃下反应24h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品分别记为21-3,21-4。21-3共33.6mg,产率为68%,21-4共10.4mg,产率为15%。Under air, into a dry 38 mL sealed tube was added Pd(OAc) 2 (4.5 mg, 0.02 mmol, 10 mol%), AgOAc (100.1 mg, 0.6 mmol, 3 equiv.), 2-hydroxypyridine (3.8 mg, 0.04 mmol. , 20 mol%), then Tf 2 NH (56.2 mg, 0.2 mmol, 1.0 equiv) was added in the glove box, and finally DCM (1.6 mL), HFIP (0.4 mL), ethyl acrylate (2.6 μL, 0.3 mmol, 1.5 equiv) and N-methyl-p-methylphenethylamine of formula 21-1 (0.2 mmol). The system was reacted at 90°C for 24h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. The obtained product samples were respectively recorded as 21-3 and 21-4. The total amount of 21-3 was 33.6 mg with a yield of 68%, and the total of 21-4 was 10.4 mg with a yield of 15%.
产物样品21-3的检测数据如下:The detection data of product sample 21-3 are as follows:
1H NMR(400MHz,CDCl3)δ6.99–6.94(m,2H),6.90(m,1H),4.24–4.13(m,2H),4.13–4.08(m,1H),3.20–3.02(m,1H),2.95–2.85(m,1H),2.82–2.75(s,2H),2.61(t,J=5.2Hz,1H),2.57(t,J=5.2Hz,1H),2.46(s,3H),2.28(s,3H),1.26(t,J=7.2Hz,3H).13C NMR(151MHz,CDCl3)δ172.4,137.1,135.5,131.1,128.9,127.9,127.4,60.5,60.0,46.3,42.3,41.2,24.5,21.2,14.3.HRMS Calcd for C15H22NO2[M+H]+248.1645,found 248.1646. 1 H NMR (400MHz, CDCl 3 )δ6.99-6.94(m,2H),6.90(m,1H),4.24-4.13(m,2H),4.13-4.08(m,1H),3.20-3.02(m ,1H),2.95–2.85(m,1H),2.82–2.75(s,2H),2.61(t,J=5.2Hz,1H),2.57(t,J=5.2Hz,1H),2.46(s, 3H), 2.28(s, 3H), 1.26(t, J=7.2Hz, 3H). 13 C NMR (151MHz, CDCl 3 )δ172.4, 137.1, 135.5, 131.1, 128.9, 127.9, 127.4, 60.5, 60.0, 46.3 ,42.3,41.2,24.5,21.2,14.3.HRMS Calcd for C 15 H 22 NO 2 [M+H] + 248.1645,found 248.1646.
产物样品21-4的检测数据如下:The detection data of product sample 21-4 are as follows:
1H NMR(400MHz,CDCl3)δ7.92(d,J=16.0Hz,1H),7.27(s,1H),6.95(s,1H),6.34(d,J=16.0Hz,1H),4.26(q,J=7.2Hz,2H),4.21–4.13(m,3H),3.18–3.08(m,1H),3.03–2.65(m,4H),2.58(dd,J=15.2,5.2Hz,1H),2.30(s,3H),1.34(t,J=7.2Hz,3H),1.26(t,J=7.1Hz,3H).13C NMR(151MHz,CDCl3)δ172.2,167.1,141.7,137.7,135.7,133.3,130.5,130.1,125.8,119.8,60.7,60.6,60.1,45.7,42.1,40.8,22.0,21.1,14.4,14.3.HRMSCalcd for C20H28NO4[M+H]+346.2013,found 346.2014. 1 H NMR (400 MHz, CDCl 3 ) δ 7.92 (d, J=16.0 Hz, 1H), 7.27 (s, 1H), 6.95 (s, 1H), 6.34 (d, J=16.0 Hz, 1H), 4.26 (q, J=7.2Hz, 2H), 4.21–4.13 (m, 3H), 3.18–3.08 (m, 1H), 3.03–2.65 (m, 4H), 2.58 (dd, J=15.2, 5.2Hz, 1H ), 2.30(s, 3H), 1.34(t, J=7.2Hz, 3H), 1.26(t, J=7.1Hz, 3H). 13 C NMR(151MHz, CDCl 3 )δ172.2,167.1,141.7,137.7, 135.7,133.3,130.5,130.1,125.8,119.8,60.7,60.6,60.1,45.7,42.1,40.8,22.0,21.1,14.4,14.3.HRMSCalcd for C 20 H 28 NO 4 [M+H] + 346.2013,found 346.2 .
实施例22Example 22
在空气下,往干燥的38mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,10mol%),AgOAc(66.8mg,0.4mmol,2equiv.),2-羟基吡啶(3.8mg,0.04mmol,20mol%),再在手套箱中加入Tf2NH(56.2mg,0.2mmol,1.0equiv),最后依次加入DCM(1.6mL),HFIP(0.4mL),丙烯酸乙酯(26.1μL,0.24mmol,1.2equiv)和式22-1所示的N-甲基对甲氧基苯乙胺(0.2mmol)。体系在90℃下反应12h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品分别记为22-3,22-4。22-3共28.9mg,产率为55%,22-4共9.4mg,产率为13%。Under air, into a dry 38 mL sealed tube was added Pd(OAc) 2 (4.5 mg, 0.02 mmol, 10 mol%), AgOAc (66.8 mg, 0.4 mmol, 2 equiv.), 2-hydroxypyridine (3.8 mg, 0.04 mmol. , 20 mol%), then Tf 2 NH (56.2 mg, 0.2 mmol, 1.0 equiv) was added in the glove box, and finally DCM (1.6 mL), HFIP (0.4 mL), ethyl acrylate (26.1 μL, 0.24 mmol, 1.2 equiv) and N-methyl-p-methoxyphenethylamine of formula 22-1 (0.2 mmol). The system was reacted at 90 °C for 12 h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. The obtained product samples were recorded as 22-3 and 22-4, respectively. The total amount of 22-3 was 28.9 mg with a yield of 55%, and the total of 22-4 was 9.4 mg with a yield of 13%.
产物样品22-3的检测数据如下:The detection data of product sample 22-3 are as follows:
1H NMR(400MHz,CDCl3)δ7.00(d,J=8.4Hz,1H),6.73(dd,J=8.4,2.4Hz,1H),6.63(d,J=2.4Hz,1H),4.22–4.15(m,2H),4.12(dd,J=7.6,5.2Hz,1H),3.76(s,3H),3.10(ddd,J=12.8,9.6,4.8Hz,1H),2.91–2.76(m,3H),2.63–2.53(m,2H),2.47(s,3H),1.26(t,J=7.2Hz,3H).13C NMR(151MHz,CDCl3)δ172.3,157.8,138.3,130.0,126.1,113.0,112.0,60.6,60.1,55.3,46.3,42.2,41.1,24.0,14.3.HRMS Calcd for C15H22NO3[M+H]+264.1594,found 264.1595. 1 H NMR (400MHz, CDCl 3 ) δ 7.00 (d, J=8.4Hz, 1H), 6.73 (dd, J=8.4, 2.4Hz, 1H), 6.63 (d, J=2.4Hz, 1H), 4.22 –4.15(m,2H),4.12(dd,J=7.6,5.2Hz,1H),3.76(s,3H),3.10(ddd,J=12.8,9.6,4.8Hz,1H),2.91–2.76(m , 3H), 2.63–2.53(m, 2H), 2.47(s, 3H), 1.26(t, J=7.2Hz, 3H). 13 C NMR (151MHz, CDCl 3 )δ172.3, 157.8, 138.3, 130.0, 126.1 ,113.0,112.0,60.6,60.1,55.3,46.3,42.2,41.1,24.0,14.3.HRMS Calcd for C 15 H 22 NO 3 [M+H] + 264.1594,found 264.1595.
产物样品22-4的检测数据如下:The detection data of product sample 22-4 are as follows:
1H NMR(400MHz,CDCl3)δ7.92(d,J=16.0Hz,1H),6.98(d,J=2.4Hz,1H),6.71(d,J=2.0Hz,1H),6.33(d,J=16.0Hz,1H),4.27(q,J=7.2Hz,2H),4.23–4.11(m,3H),3.79(s,3H),3.19–3.08(m,1H),2.96–2.79(m,3H),2.72–2.64(m,1H),2.59(dd,J=15.6,5.6Hz,1H),2.46(s,3H),1.34(t,J=7.2Hz,3H),1.26(t,J=7.2Hz,3H).13C NMR(151MHz,CDCl3)δ172.1,167.0,157.7,141.5,134.6,125.8,120.2,114.8,110.6,60.7,60.3,55.4,45.7,42.0,40.8,31.0,21.7,14.4,14.3.HRMS Calcd for C20H28NO5[M+H]+362.1962,found362.1963. 1 H NMR (400 MHz, CDCl 3 ) δ 7.92 (d, J=16.0 Hz, 1H), 6.98 (d, J=2.4 Hz, 1H), 6.71 (d, J=2.0 Hz, 1H), 6.33 (d , J=16.0Hz, 1H), 4.27 (q, J=7.2Hz, 2H), 4.23–4.11 (m, 3H), 3.79 (s, 3H), 3.19–3.08 (m, 1H), 2.96–2.79 ( m,3H),2.72–2.64(m,1H),2.59(dd,J=15.6,5.6Hz,1H),2.46(s,3H),1.34(t,J=7.2Hz,3H),1.26(t , J=7.2Hz, 3H). 13 C NMR (151MHz, CDCl 3 )δ172.1, 167.0, 157.7, 141.5, 134.6, 125.8, 120.2, 114.8, 110.6, 60.7, 60.3, 55.4, 45.7, 42.0, 40.8, 31.0, 21.7, 14.4, 14.3. HRMS Calcd for C 20 H 28 NO 5 [M+H] + 362.1962, found362.1963.
实施例23Example 23
在空气下,往干燥的38mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,10mol%),AgOAc(66.8mg,0.4mmol,2equiv.),2-羟基吡啶(3.8mg,0.04mmol,20mol%),再在手套箱中加入Tf2NH(56.2mg,0.2mmol,1.0equiv),最后依次加入DCM(1.6mL),HFIP(0.4mL),丙烯酸乙酯(26.1μL,0.24mmol,1.2equiv)和式23-1所示的N-甲基对氟苯乙胺(0.2mmol)。体系在90℃下反应12h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品分别记为23-3,23-4。23-3共27.1mg,产率为54%,23-4共5.6mg,产率为8%。Under air, into a dry 38 mL sealed tube was added Pd(OAc) 2 (4.5 mg, 0.02 mmol, 10 mol%), AgOAc (66.8 mg, 0.4 mmol, 2 equiv.), 2-hydroxypyridine (3.8 mg, 0.04 mmol. , 20 mol%), then Tf 2 NH (56.2 mg, 0.2 mmol, 1.0 equiv) was added in the glove box, and finally DCM (1.6 mL), HFIP (0.4 mL), ethyl acrylate (26.1 μL, 0.24 mmol, 1.2 equiv) and N-methyl-p-fluorophenethylamine of formula 23-1 (0.2 mmol). The system was reacted at 90 °C for 12 h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. The obtained product samples were recorded as 23-3 and 23-4, respectively. The total of 23-3 was 27.1 mg with a yield of 54%, and the total of 23-4 was 5.6 mg with a yield of 8%.
产物样品23-3的检测数据如下:The detection data of product sample 23-3 are as follows:
1H NMR(400MHz,CDCl3)δ7.04(dd,J=7.2,8.4Hz,1H),6.90–6.76(m,2H),4.25–4.06(m,3H),3.14–3.02(m,1H),2.96–2.74(m,3H),2.67–2.54(m,2H),2.47(s,3H),1.25(t,J=7.2Hz,3H).13C NMR(151MHz,CDCl3)δ172.0,161.1(d,J=244.2Hz),139.1(d,J=6.0Hz),130.4(d,J=7.7Hz),129.6,113.8(d,J=7.1Hz),113.6(d,J=7.1Hz),60.7,59.9,46.3,42.2,40.7,24.4,14.3.HRMS Calcd for C14H19FNO2[M+H]+252.1394,found252.1394. 1 H NMR (400 MHz, CDCl 3 ) δ 7.04 (dd, J=7.2, 8.4 Hz, 1H), 6.90-6.76 (m, 2H), 4.25-4.06 (m, 3H), 3.14-3.02 (m, 1H) ), 2.96–2.74 (m, 3H), 2.67–2.54 (m, 2H), 2.47 (s, 3H), 1.25 (t, J=7.2Hz, 3H). 13 C NMR (151MHz, CDCl 3 )δ172. 0,161.1(d,J=244.2Hz),139.1(d,J=6.0Hz),130.4(d,J=7.7Hz),129.6,113.8(d,J=7.1Hz),113.6(d,J=7.1Hz ),60.7,59.9,46.3,42.2,40.7,24.4,14.3.HRMS Calcd for C 14 H 19 FNO 2 [M+H] + 252.1394,found252.1394.
产物样品23-4的检测数据如下:The detection data of product sample 23-4 are as follows:
1H NMR(400MHz,CDCl3)δ7.89(d,J=15.6Hz,1H),7.13(dd,J=9.2,2.4Hz,1H),6.88(dd,J=8.8,2.4Hz,1H),6.33(d,J=16.0Hz,1H),4.27(q,J=7.2Hz,2H),4.22–4.14(m,3H),3.17–3.09(m,1H),2.96–2.82(m,3H),2.74–2.68(m,1H),2.59(dd,J=15.2,5.6Hz,1H),2.47(s,3H),1.34(t,J=7.2Hz,3H),1.26(t,J=7.2Hz,4H).13C NMR(151MHz,CDCl3)δ171.8,166.7,161.0(d,J=245.1Hz),140.4,140.1,135.5(d,J=7.3Hz),129.1,121.3,115.8(d,J=20.8Hz),111.9(d,J=20.1Hz),60.8,60.1,45.7,42.0,40.4,22.1,14.4(d,J=8.0Hz),14.3(d,J=5.0Hz).HRMS Calcd for C19H25FNO4[M+H]+350.1762,found350.1763. 1 H NMR (400MHz, CDCl 3 ) δ 7.89 (d, J=15.6Hz, 1H), 7.13 (dd, J=9.2, 2.4Hz, 1H), 6.88 (dd, J=8.8, 2.4Hz, 1H) ,6.33(d,J=16.0Hz,1H),4.27(q,J=7.2Hz,2H),4.22-4.14(m,3H),3.17-3.09(m,1H),2.96-2.82(m,3H) ), 2.74–2.68(m, 1H), 2.59(dd, J=15.2, 5.6Hz, 1H), 2.47(s, 3H), 1.34(t, J=7.2Hz, 3H), 1.26(t, J= 7.2Hz, 4H). 13 C NMR (151MHz, CDCl 3 )δ171.8, 166.7, 161.0 (d, J=245.1 Hz), 140.4, 140.1, 135.5 (d, J=7.3 Hz), 129.1, 121.3, 115.8 (d HRMS Calcd for C 19 H 25 FNO 4 [M+H] + 350.1762, found350.1763.
实施例24Example 24
在空气下,往干燥的38mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,10mol%),AgOAc(66.8mg,0.4mmol,2equiv.),2-羟基吡啶(3.8mg,0.04mmol,20mol%),再在手套箱中加入Tf2NH(56.2mg,0.2mmol,1.0equiv),最后依次加入DCM(1.6mL),HFIP(0.4mL),丙烯酸乙酯(32.6μL,0.3mmol,1.5equiv)和式24-1所示的N-甲基-2,4-二氯苯乙胺(0.2mmol)。体系在90℃下反应24h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品记为24-3,共31.3mg,产率为52%。产物样品24-3的检测数据如下:Under air, into a dry 38 mL sealed tube was added Pd(OAc) 2 (4.5 mg, 0.02 mmol, 10 mol%), AgOAc (66.8 mg, 0.4 mmol, 2 equiv.), 2-hydroxypyridine (3.8 mg, 0.04 mmol. , 20 mol%), then Tf 2 NH (56.2 mg, 0.2 mmol, 1.0 equiv) was added in the glove box, and finally DCM (1.6 mL), HFIP (0.4 mL), ethyl acrylate (32.6 μL, 0.3 mmol, 1.5 equiv) and N-methyl-2,4-dichlorophenethylamine of formula 24-1 (0.2 mmol). The system was reacted at 90°C for 24h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. The resulting product sample was designated as 24-3, a total of 31.3 mg, and a yield of 52%. The detection data of product sample 24-3 are as follows:
1H NMR(400MHz,CDCl3)δ7.26(d,J=2.0Hz,1H),7.04(d,J=1.6Hz,1H),4.30–4.04(m,3H),3.13–3.06(m,1H),2.95–2.72(m,3H),2.63(ddd,J=17.6,5.2,2.8Hz,1H),2.55(dd,J=15.2,5.6Hz,1H),2.44(s,3H),1.26(t,J=7.2Hz,3H).13C NMR(101MHz,CDCl3)δ171.6,140.7,135.0,131.8,130.8,127.1,125.9,60.7,59.6,45.0,41.8,40.2,22.3,14.2.HRMS Calcd for C14H18Cl2NO2[M+H]+302.0709,found 302.0709. 1 H NMR (400 MHz, CDCl 3 ) δ 7.26 (d, J=2.0 Hz, 1H), 7.04 (d, J=1.6 Hz, 1H), 4.30-4.04 (m, 3H), 3.13-3.06 (m, 1H), 2.95–2.72 (m, 3H), 2.63 (ddd, J=17.6, 5.2, 2.8Hz, 1H), 2.55 (dd, J=15.2, 5.6Hz, 1H), 2.44 (s, 3H), 1.26 (t, J=7.2Hz, 3H). 13 C NMR (101 MHz, CDCl 3 ) δ 171.6, 140.7, 135.0, 131.8, 130.8, 127.1, 125.9, 60.7, 59.6, 45.0, 41.8, 40.2, 22.3, 14.2. HRMS Calcd for C 14 H 18 Cl 2 NO 2 [M+H] + 302.0709, found 302.0709.
实施例25Example 25
在空气下,往干燥的38mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,10mol%),AgOAc(100.2mg,0.6mmol,3equiv.),2-羟基吡啶(3.8mg,0.04mmol,20mol%),再在手套箱中加入Tf2NH(56.2mg,0.2mmol,1.0equiv),最后依次加入DCM(1.6mL),HFIP(0.4mL),丙烯酸乙酯(26.1μL,0.24mmol,1.2equiv)和式25-1所示的苯乙胺盐酸盐(55.3mg,0.2mmol)。体系在90℃下反应12h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品记为25-3。25-3cis共44.1mg,产率为65%,25-3trans共23.1mg,产率为34%。Pd(OAc) 2 (4.5 mg, 0.02 mmol, 10 mol%), AgOAc (100.2 mg, 0.6 mmol, 3 equiv.), 2-hydroxypyridine (3.8 mg, 0.04 mmol) were added to a dry 38 mL sealed tube under air. , 20 mol%), then Tf 2 NH (56.2 mg, 0.2 mmol, 1.0 equiv) was added in the glove box, and finally DCM (1.6 mL), HFIP (0.4 mL), ethyl acrylate (26.1 μL, 0.24 mmol, 1.2 equiv) and phenethylamine hydrochloride of formula 25-1 (55.3 mg, 0.2 mmol). The system was reacted at 90 °C for 12 h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. The resulting product sample was designated as 25-3. 25-3 cis totaled 44.1 mg with a 65% yield, and 25-3 trans totaled 23.1 mg with a 34% yield.
产物样品25-3cis的检测数据如下:The detection data of the product sample 25-3 cis are as follows:
1H NMR(400MHz,CDCl3)δ7.18–7.16(m,1H),7.14(s,1H),7.12–7.11(m,1H),4.48(dd,J=8.6,3.4Hz,1H),4.22–4.10(m,4H),3.63(s,1H),3.29(m,1H),3.20(qd,J=12.7,3.8Hz,2H),3.01(dd,J=16.6,3.5Hz,1H),2.87(ddd,J=32.9,16.4,8.8Hz,2H),2.62(dd,J=16.2,4.6Hz,1H),1.26(t,J=7.1Hz,6H).13C NMR(151MHz,CDCl3)δ172.3,171.9,138.0,136.3,132.5,130.4,127.4,125.8,61.1,60.8,52.7,45.4,40.4,39.8,34.0,14.3,14.2.HRMS Calcd for C17H23ClNO4[M+H]+340.1310,found340.1311. 1 H NMR (400MHz, CDCl 3 ) δ 7.18-7.16 (m, 1H), 7.14 (s, 1H), 7.12-7.11 (m, 1H), 4.48 (dd, J=8.6, 3.4Hz, 1H), 4.22–4.10 (m, 4H), 3.63 (s, 1H), 3.29 (m, 1H), 3.20 (qd, J=12.7, 3.8Hz, 2H), 3.01 (dd, J=16.6, 3.5Hz, 1H) , 2.87 (ddd, J=32.9, 16.4, 8.8Hz, 2H), 2.62 (dd, J=16.2, 4.6Hz, 1H), 1.26 (t, J=7.1Hz, 6H). 13 C NMR (151MHz, CDCl 3 )δ172.3,171.9,138.0,136.3,132.5,130.4,127.4,125.8,61.1,60.8,52.7,45.4,40.4,39.8,34.0,14.3,14.2.HRMS Calcd for C 17 H 23 ClNO 4 [M+H] + 340.1310,found340.1311.
产物样品25-3trans的检测数据如下:The detection data of the product sample 25-3 trans are as follows:
1H NMR(400MHz,CDCl3)δ7.16(dd,J=8.3,2.1Hz,1H),7.11(d,J=8.3Hz,1H),7.08(s,1H),4.48(dd,J=9.9,3.5Hz,1H),4.26–4.08(m,4H),3.26(m,2H),2.98–2.89(m,1H),2.84(dd,J=16.1,9.9Hz,1H),2.78–2.64(m,2H),2.58(dd,J=15.9,4.3Hz,1H),2.37–2.18(s,br,1H),1.26(dt,J=9.9,7.1Hz,6H).13C NMR(151MHz,CDCl3)δ172.4,171.9,139.1,136.3,132.2,130.2,127.3,126.5,60.9,60.7,52.3,43.0,40.5,40.1,34.1,14.3,14.3.HRMS Calcd for C17H23ClNO4[M+H]+340.1310,found340.1311. 1 H NMR (400 MHz, CDCl 3 ) δ 7.16 (dd, J=8.3, 2.1 Hz, 1H), 7.11 (d, J=8.3 Hz, 1H), 7.08 (s, 1H), 4.48 (dd, J= 9.9, 3.5Hz, 1H), 4.26–4.08 (m, 4H), 3.26 (m, 2H), 2.98–2.89 (m, 1H), 2.84 (dd, J=16.1, 9.9Hz, 1H), 2.78–2.64 (m, 2H), 2.58 (dd, J=15.9, 4.3Hz, 1H), 2.37–2.18 (s, br, 1H), 1.26 (dt, J=9.9, 7.1Hz, 6H). 13 C NMR (151MHz) , CDCl 3 )δ172.4,171.9,139.1,136.3,132.2,130.2,127.3,126.5,60.9,60.7,52.3,43.0,40.5,40.1,34.1,14.3,14.3.HRMS Calcd for C 17 H 23 ClNO 4 [M+ H] + 340.1310,found340.1311.
实施例26Example 26
在空气下,往干燥的38mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,10mol%),AgOAc(100.2mg,0.6mmol,3equiv.),2-羟基吡啶(3.8mg,0.04mmol,20mol%),再在手套箱中加入Tf2NH(56.2mg,0.2mmol,1.0equiv),最后依次加入DCM(1.6mL),HFIP(0.4mL),丙烯酸乙酯(32.6μL,0.3mmol,1.5equiv)和式26-1所示的苯乙胺(33.2μL,0.2mmol)。体系在90℃下反应12h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品分别记为26-3,26-4。26-3trans共22.2mg,产率为40%,26-3cis共11.6mg,产率为21%。26-4共18.8mg,产率为25%。Pd(OAc) 2 (4.5 mg, 0.02 mmol, 10 mol%), AgOAc (100.2 mg, 0.6 mmol, 3 equiv.), 2-hydroxypyridine (3.8 mg, 0.04 mmol) were added to a dry 38 mL sealed tube under air. , 20 mol%), then Tf 2 NH (56.2 mg, 0.2 mmol, 1.0 equiv) was added to the glove box, and finally DCM (1.6 mL), HFIP (0.4 mL), ethyl acrylate (32.6 μL, 0.3 mmol, 1.5 equiv) and phenethylamine of formula 26-1 (33.2 μL, 0.2 mmol). The system was reacted at 90 °C for 12 h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. The obtained product samples were denoted as 26-3 and 26-4, respectively. 26-3 trans totaled 22.2 mg with a yield of 40%, and 26-3 cis totaled 11.6 mg with a yield of 21%. 18.8 mg of 26-4 in 25% yield.
产物样品26-3trans的检测数据如下:The detection data of the product sample 26-3 trans are as follows:
1H NMR(400MHz,CDCl3)δ7.20–7.05(m,4H),4.67(t,J=6.9Hz,1H),4.20(q,J=7.2Hz,2H),3.92(dd,J=8.9,4.8Hz,1H),3.75(s,3H),3.12(dd,J=16.2,4.8Hz,1H),2.99(dd,J=16.1,8.8Hz,1H),2.77–2.71(m,2H),2.48(s,br,1H),1.29(t,J=7.1Hz,3H).13CNMR(151MHz,CDCl3)δ173.7,172.0,136.7,133.2,129.4,126.8,126.5,126.5,60.8,52.3,51.6,51.4,41.8,31.8,14.3.HRMS Calcd for C15H19NNaO4[M+Na]+300.1206,found300.1206. 1 H NMR (400 MHz, CDCl 3 ) δ 7.20-7.05 (m, 4H), 4.67 (t, J=6.9 Hz, 1H), 4.20 (q, J=7.2 Hz, 2H), 3.92 (dd, J= 8.9, 4.8Hz, 1H), 3.75 (s, 3H), 3.12 (dd, J=16.2, 4.8Hz, 1H), 2.99 (dd, J=16.1, 8.8Hz, 1H), 2.77–2.71 (m, 2H ), 2.48(s, br, 1H), 1.29(t, J=7.1Hz, 3H). 13 CNMR(151MHz, CDCl 3 )δ173.7,172.0,136.7,133.2,129.4,126.8,126.5,126.5,60.8,52.3 ,51.6,51.4,41.8,31.8,14.3.HRMS Calcd for C 15 H 19 NNaO 4 [M+Na] + 300.1206,found300.1206.
产物样品26-3cis的检测数据如下:The detection data of the product sample 26-3 cis are as follows:
1H NMR(400MHz,CDCl3)δ7.20–7.11(m,4H),4.58–4.49(m,1H),4.18(q,J=7.2Hz,2H),3.79(s,3H),3.75(dd,J=10.6,4.5Hz,1H),3.12–2.95(m,3H),2.72(dd,J=16.6,9.3Hz,1H),1.26(t,J=7.1Hz,3H).13C NMR(151MHz,CDCl3)δ173.1,172.3,136.6,134.3,129.5,126.7,126.6,125.1,60.9,55.6,53.2,52.4,41.4,32.9,14.3.HRMS Calcd forC15H19NNaO4[M+Na]+300.1206,found 300.1206. 1 H NMR (400MHz, CDCl 3 ) δ 7.20-7.11 (m, 4H), 4.58-4.49 (m, 1H), 4.18 (q, J=7.2Hz, 2H), 3.79 (s, 3H), 3.75 ( dd, J=10.6, 4.5Hz, 1H), 3.12–2.95 (m, 3H), 2.72 (dd, J=16.6, 9.3Hz, 1H), 1.26 (t, J=7.1Hz, 3H). 13 C NMR (151MHz, CDCl 3 )δ173.1,172.3,136.6,134.3,129.5,126.7,126.6,125.1,60.9,55.6,53.2,52.4,41.4,32.9,14.3.HRMS Calcd forC 15 H 19 NNaO 4 [M+Na] + 300.1206, found 300.1206.
产物样品26-4的检测数据如下:The detection data of product sample 26-4 are as follows:
1H NMR(600MHz,CDCl3)δ7.94(d,J=15.8Hz,1H),7.45(d,J=7.8Hz,1H),7.23(t,J=7.7Hz,1H),7.18(d,J=7.8Hz,1H),6.36(d,J=15.8Hz,1H),4.55(d,J=9.1Hz,1H),4.28(q,J=7.2Hz,2H),4.18(q,J=7.1Hz,2H),3.82(s,3H),3.72(dd,J=11.4,3.7Hz,1H),3.23(dd,J=16.1,3.8Hz,1H),3.05(dd,J=16.7,3.1Hz,1H),2.95(dd,J=16.2,11.3Hz,1H),2.72(dd,J=16.7,9.2Hz,1H),1.86–1.52(s,br,1H),1.35(t,J=7.1Hz,3H),1.26(t,J=7.1Hz,3H).13C NMR(151MHz,CDCl3)δ172.9,172.1,166.9,141.5,137.5,134.2,133.7,126.9,126.6,125.1,120.8,60.9,60.8,55.4,53.4,52.5,41.6,30.3,14.4,14.3.HRMSCalcd for C20H25NNaO6[M+Na]+398.1574,found 398.1571. 1 H NMR (600 MHz, CDCl 3 ) δ 7.94 (d, J=15.8 Hz, 1H), 7.45 (d, J=7.8 Hz, 1H), 7.23 (t, J=7.7 Hz, 1H), 7.18 (d ,J=7.8Hz,1H),6.36(d,J=15.8Hz,1H),4.55(d,J=9.1Hz,1H),4.28(q,J=7.2Hz,2H),4.18(q,J =7.1Hz,2H),3.82(s,3H),3.72(dd,J=11.4,3.7Hz,1H),3.23(dd,J=16.1,3.8Hz,1H),3.05(dd,J=16.7, 3.1Hz, 1H), 2.95(dd, J=16.2, 11.3Hz, 1H), 2.72(dd, J=16.7, 9.2Hz, 1H), 1.86–1.52(s, br, 1H), 1.35(t, J = 7.1Hz, 3H), 1.26 (t, J = 7.1Hz, 3H). 13 C NMR (151MHz, CDCl 3 ) δ 172.9, 172.1, 166.9, 141.5, 137.5, 134.2, 133.7, 126.9, 126.6, 125.1, 120.8, 60.9, 60.8, 55.4, 53.4, 52.5, 41.6, 30.3, 14.4, 14.3. HRMSCalcd for C 20 H 25 NNaO 6 [M+Na] + 398.1574, found 398.1571.
实施例27Example 27
在空气下,往干燥的120mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,2mol%),AgOAc(334mg,2mmol,2equiv.),2-羟基吡啶(9.5mg,0.1mmol,10mol%),再在手套箱中加入Tf2NH(281mg,1.0mmol,1.0equiv),最后依次加入DCM(6.4mL),HFIP(1.6mL),丙烯酸乙酯(131μL,1.2mmol,1.2equiv)和式27-1所示的邻甲基苯乙胺(141μL,1.0mmol)。体系在90℃下反应24h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品记为1-3,共207.5mg,产率为89%。Under air, into a dry 120 mL sealed tube was added Pd(OAc) 2 (4.5 mg, 0.02 mmol, 2 mol%), AgOAc (334 mg, 2 mmol, 2 equiv.), 2-hydroxypyridine (9.5 mg, 0.1 mmol, 10 mol. %), then Tf 2 NH (281 mg, 1.0 mmol, 1.0 equiv) was added in the glove box, and finally DCM (6.4 mL), HFIP (1.6 mL), ethyl acrylate (131 μL, 1.2 mmol, 1.2 equiv) and o-methylphenethylamine of formula 27-1 (141 μL, 1.0 mmol). The system was reacted at 90°C for 24h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. The resulting product samples were designated as 1-3, a total of 207.5 mg, and a yield of 89%.
实施例28Example 28
在空气下,往干燥的120mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,1mol%),AgOAc(668mg,4mmol,4equiv.),2-羟基吡啶(9.5mg,0.1mmol,5mol%),再在手套箱中加入Tf2NH(562mg,2.0mmol,1.0equiv),最后依次加入DCM(8mL),HFIP(2mL),丙烯酸乙酯(262μL,2.4mmol,1.2equiv)和式28-1所示的邻甲基苯乙胺(282μL,2.0mmol)。体系在90℃下反应48h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品记为1-3,共284.0mg,产率为61%。Under air, into a dry 120 mL sealed tube was added Pd(OAc) 2 (4.5 mg, 0.02 mmol, 1 mol%), AgOAc (668 mg, 4 mmol, 4 equiv.), 2-hydroxypyridine (9.5 mg, 0.1 mmol, 5 mol. %), then Tf 2 NH (562 mg, 2.0 mmol, 1.0 equiv) was added in the glove box, and finally DCM (8 mL), HFIP (2 mL), ethyl acrylate (262 μL, 2.4 mmol, 1.2 equiv) and formula 28 were added in sequence - o-methylphenethylamine of 1 (282 μL, 2.0 mmol). The system was reacted at 90°C for 48h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. The resulting product samples were designated as 1-3, a total of 284.0 mg, and a yield of 61%.
实施例29Example 29
在空气下,往干燥的38mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,10mol%),AgOAc(66.8mg,0.4mmol,2equiv.),2-羟基吡啶(3.8mg,0.04mmol,20mol%),再在手套箱中加入Tf2NH(56.2mg,0.2mmol,1.0equiv),最后依次加入DCM(1.6mL),HFIP(0.4mL),丙烯酸甲酯(21.7μL,0.24mmol,1.2equiv)和式29-1所示的邻甲基苯乙胺(0.2mmol)。体系在90℃下反应12h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品记为29-3,核磁产率为81%(内标:二溴甲烷0.2mmol,14μL)。Under air, into a dry 38 mL sealed tube was added Pd(OAc) 2 (4.5 mg, 0.02 mmol, 10 mol%), AgOAc (66.8 mg, 0.4 mmol, 2 equiv.), 2-hydroxypyridine (3.8 mg, 0.04 mmol. , 20 mol%), then Tf 2 NH (56.2 mg, 0.2 mmol, 1.0 equiv) was added in the glove box, and finally DCM (1.6 mL), HFIP (0.4 mL), methyl acrylate (21.7 μL, 0.24 mmol, 1.2 equiv) and o-methylphenethylamine of formula 29-1 (0.2 mmol). The system was reacted at 90 °C for 12 h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. The obtained product sample was designated as 29-3, and the NMR yield was 81% (internal standard: dibromomethane 0.2 mmol, 14 μL).
实施例30Example 30
在空气下,往干燥的38mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,10mol%),AgOAc(66.8mg,0.4mmol,2equiv.),2-羟基吡啶(3.8mg,0.04mmol,20mol%),再在手套箱中加入Tf2NH(56.2mg,0.2mmol,1.0equiv),最后依次加入DCM(1.6mL),HFIP(0.4mL),丙烯酸正丁酯(34.6μL,0.24mmol,1.2equiv)和式30-1所示的邻甲基苯乙胺(0.2mmol)。体系在90℃下反应12h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品记为30-3,共44.4mg,产率为85%。Under air, into a dry 38 mL sealed tube was added Pd(OAc) 2 (4.5 mg, 0.02 mmol, 10 mol%), AgOAc (66.8 mg, 0.4 mmol, 2 equiv.), 2-hydroxypyridine (3.8 mg, 0.04 mmol. , 20 mol%), then Tf 2 NH (56.2 mg, 0.2 mmol, 1.0 equiv) was added in the glove box, and finally DCM (1.6 mL), HFIP (0.4 mL), n-butyl acrylate (34.6 μL, 0.24 mmol) were added in sequence , 1.2equiv) and o-methylphenethylamine of formula 30-1 (0.2mmol). The system was reacted at 90 °C for 12 h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. The resulting product sample was designated as 30-3, a total of 44.4 mg, and a yield of 85%.
产物样品30-3的检测数据如下:The detection data of product sample 30-3 are as follows:
1H NMR(400MHz,CDCl3)δ7.06(t,J=7.2,7.2Hz,1H),7.01(d,J=7.2Hz,1H),6.94(d,J=7.2Hz,1H),4.46(dd,J=9.6,3.6Hz,1H),4.11(t,J=6.6Hz,2H),3.27–3.23(m,1H),3.08–3.04(m,1H),2.87–2.84(m,1H),2.79–2.75(m,1H),2.71–2.60(m,4H),2.21(s,3H),1.62–1.57(m,2H),1.38–1.32(m,2H),0.91(t,J=7.2Hz,3H).13C NMR(151MHz,CDCl3)δ172.5,137.2,136.8,133.8,127.9,125.5,123.6,64.6,53.0,41.1,40.4,30.7,27.0,19.4,19.2,13.7.HRMS Calcd for C14H20NO2[M+H]+234.1489,found 234.1489. 1 H NMR (400 MHz, CDCl 3 ) δ 7.06 (t, J=7.2, 7.2 Hz, 1H), 7.01 (d, J=7.2 Hz, 1H), 6.94 (d, J=7.2 Hz, 1H), 4.46 (dd, J=9.6, 3.6Hz, 1H), 4.11 (t, J=6.6Hz, 2H), 3.27–3.23 (m, 1H), 3.08–3.04 (m, 1H), 2.87–2.84 (m, 1H) ), 2.79–2.75 (m, 1H), 2.71–2.60 (m, 4H), 2.21 (s, 3H), 1.62–1.57 (m, 2H), 1.38–1.32 (m, 2H), 0.91 (t, J =7.2Hz, 3H). 13 C NMR (151MHz, CDCl 3 )δ172.5, 137.2, 136.8, 133.8, 127.9, 125.5, 123.6, 64.6, 53.0, 41.1, 40.4, 30.7, 27.0, 19.4, 19.2, 13.7. HRMS Calcd for C 14 H 20 NO 2 [M+H] + 234.1489, found 234.1489.
实施例31Example 31
在空气下,往干燥的38mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,10mol%),AgOAc(66.8mg,0.4mmol,2equiv.),2-羟基吡啶(3.8mg,0.04mmol,20mol%),再在手套箱中加入Tf2NH(56.2mg,0.2mmol,1.0equiv),最后依次加入DCM(1.6mL),HFIP(0.4mL),丙烯酸叔丁酯(34.8μL,0.24mmol,1.2equiv)和式31-1所示的邻甲基苯乙胺(0.2mmol)。体系在90℃下反应12h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品记为31-3,核磁产率为20%(内标:二溴甲烷0.2mmol,14μL)。Under air, into a dry 38 mL sealed tube was added Pd(OAc) 2 (4.5 mg, 0.02 mmol, 10 mol%), AgOAc (66.8 mg, 0.4 mmol, 2 equiv.), 2-hydroxypyridine (3.8 mg, 0.04 mmol. , 20 mol%), then Tf 2 NH (56.2 mg, 0.2 mmol, 1.0 equiv) was added to the glove box, and finally DCM (1.6 mL), HFIP (0.4 mL), tert-butyl acrylate (34.8 μL, 0.24 mmol) were added in sequence , 1.2equiv) and o-methylphenethylamine of formula 31-1 (0.2mmol). The system was reacted at 90 °C for 12 h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. The obtained product sample was designated as 31-3, and the NMR yield was 20% (internal standard: dibromomethane 0.2 mmol, 14 μL).
实施例32Example 32
在空气下,往干燥的38mL封管中加入Pd(OAc)2(4.5mg,0.02mmol,10mol%),AgOAc(66.8mg,0.4mmol,2equiv.),2-羟基吡啶(3.8mg,0.04mmol,20mol%),再在手套箱中加入Tf2NH(56.2mg,0.2mmol,1.0equiv),最后依次加入DCM(1.6mL),HFIP(0.4mL),乙烯基膦酸二乙酯(36.9μL,0.24mmol,1.2equiv)和式32-2所示的邻甲基苯乙胺(0.2mmol)。体系在90℃下反应12h,然后冷却至室温,减压蒸出溶剂和剩余丙烯酸乙酯,然后再往剩余物中加入二氯甲烷和饱和碳酸钠进行萃取,收集有机层,无水硫酸钠干燥后过滤,减压蒸出溶剂,剩余物经硅胶柱层析(石油醚/乙酸乙酯/三乙胺=11/1/0.4作淋洗剂)分离可得产物。所得产物样品记为32-3,核磁产率为6%(内标:二溴甲烷0.2mmol,14μL)。Under air, into a dry 38 mL sealed tube was added Pd(OAc) 2 (4.5 mg, 0.02 mmol, 10 mol%), AgOAc (66.8 mg, 0.4 mmol, 2 equiv.), 2-hydroxypyridine (3.8 mg, 0.04 mmol. , 20 mol%), then Tf 2 NH (56.2 mg, 0.2 mmol, 1.0 equiv) was added to the glove box, and finally DCM (1.6 mL), HFIP (0.4 mL), diethyl vinylphosphonate (36.9 μL) were added sequentially , 0.24mmol, 1.2equiv) and o-methylphenethylamine (0.2mmol) shown in formula 32-2. The system was reacted at 90 °C for 12 h, then cooled to room temperature, the solvent and remaining ethyl acrylate were evaporated under reduced pressure, and then dichloromethane and saturated sodium carbonate were added to the residue for extraction, the organic layer was collected, and dried over anhydrous sodium sulfate. After filtering, the solvent was evaporated under reduced pressure, and the residue was separated by silica gel column chromatography (petroleum ether/ethyl acetate/triethylamine=11/1/0.4 as eluent) to obtain the product. The obtained product sample was designated as 32-3, and the NMR yield was 6% (internal standard: dibromomethane 0.2 mmol, 14 μL).
以上所述,仅是本申请的几个实施例,并非对本申请做任何形式的限制,虽然本申请以较佳实施例揭示如上,然而并非用以限制本申请,任何熟悉本专业的技术人员,在不脱离本申请技术方案的范围内,利用上述揭示的技术内容做出些许的变动或修饰均等同于等效实施案例,均属于技术方案范围内。The above are only a few embodiments of the present application, and are not intended to limit the present application in any form. Although the present application is disclosed as above with preferred embodiments, it is not intended to limit the present application. Without departing from the scope of the technical solutions of the present application, any changes or modifications made by using the technical contents disclosed above are equivalent to equivalent implementation cases and fall within the scope of the technical solutions.
Claims (13)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910785125.2A CN110452169B (en) | 2019-08-23 | 2019-08-23 | Method for constructing tetrahydroisoquinoline compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910785125.2A CN110452169B (en) | 2019-08-23 | 2019-08-23 | Method for constructing tetrahydroisoquinoline compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110452169A CN110452169A (en) | 2019-11-15 |
CN110452169B true CN110452169B (en) | 2021-02-19 |
Family
ID=68488780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910785125.2A Active CN110452169B (en) | 2019-08-23 | 2019-08-23 | Method for constructing tetrahydroisoquinoline compounds |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110452169B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114685369B (en) * | 2022-05-17 | 2024-02-02 | 河南省科学院高新技术研究中心 | Method for preparing 1-methyl-1, 2,3, 4-tetrahydroisoquinoline by utilizing ionic liquid |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013096150A1 (en) * | 2011-12-21 | 2013-06-27 | Merck Sharp & Dohme Corp. | Substituted piperidines as hdm2 inhibitors |
-
2019
- 2019-08-23 CN CN201910785125.2A patent/CN110452169B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013096150A1 (en) * | 2011-12-21 | 2013-06-27 | Merck Sharp & Dohme Corp. | Substituted piperidines as hdm2 inhibitors |
Non-Patent Citations (6)
Title |
---|
A Conformational Restriction Approach to the Development of Dual Inhibitors of Acetylcholinesterase and Serotonin Transporter as Potential Agents for Alzheimer’s Disease;Narihiro Toda等;《Bioorg. Med. Chem.》;20030703;第11卷;4389-4415页 * |
A general approach to N-heterocyclic scaffolds using domino Heck–aza-Michael reactions;Daniel L. Priebbenow等;《Org. Biomol. Chem.,》;20101212;第9卷;1508-1515 * |
Palladium-Catalyzed Aerobic Oxidative C−H Olefination with Removable 1,2,3-Triazole Directing Group;Xiaohan Ye等;《Org. Lett》;20140813;第16卷;4448−4451 * |
Pd-Catalyzed Directed ortho-C−H Alkenylation of Phenylalanine Derivatives;Alfonso García-Rubia等;《J. Org. Chem.》;20150212;第80卷;3321−3331 * |
Preparation of Substituted Tetrahydroisoquinolines by Pd(II)- Catalyzed NH2‑Directed Insertion of Michael Acceptors into C−H Bonds Followed by NH2‑Conjugated Addition;Andrea Mancinelli等;《Organometallics》;20170215;第36卷;911-919页 * |
Versatile and highly efficient oxidative C(sp3)–H bond functionalization of tetrahydroisoquinoline promoted by bifunctional diethyl azodicarboxylate (DEAD): scope and mechanistic insights;Takuya Suga等;《Org. Chem. Front.》;20160801;第3卷;1259-1264页 * |
Also Published As
Publication number | Publication date |
---|---|
CN110452169A (en) | 2019-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6166226A (en) | Synthesis of aryl ethers | |
Hayashi et al. | Asymmetric synthesis catalyzed by chiral ferrocenylphosphine-transition-metal complexes. 8. Palladium-catalyzed asymmetric allylic amination | |
Romano et al. | Remote functionalization of α, β-unsaturated carbonyls by multimetallic sequential catalysis | |
Sehnal et al. | Emergence of palladium (IV) chemistry in synthesis and catalysis | |
Narahashi et al. | Synthesis of benzylpalladium complexes through C–O bond cleavage of benzylic carboxylates: Development of a novel palladium-catalyzed benzylation of olefins | |
CN114315917A (en) | Chiral Ferrocene PNNO Tetradentate Ligand and Its Application in Asymmetric Hydrogenation | |
CN108774271A (en) | A kind of chiral nitrogen nitrogen phosphine tridentate ligand and its application based on ferrocene frame having ferrocene frame | |
US20010008942A1 (en) | Synthesis of aryl ethers | |
CN104892547B (en) | A kind of method that catalysis of carbonyl is combined to alpha-keto amide compound | |
CN111925356B (en) | Synthesis method and application of chiral quinoline-imidazoline ligand | |
Chen et al. | Synthesis of novel macrocyclic planar chiral carbene–Ag complexes derived from [2.2] paracyclophane for Rh-catalyzed asymmetric 1, 2-additions of arylboronic acids to aromatic aldehydes | |
CN110452169B (en) | Method for constructing tetrahydroisoquinoline compounds | |
Zhao et al. | Practical by Ligand Design: A New Class of Monodentate Phosphoramidite Ligands for Rhodium‐Catalyzed Enantioselective Hydrogenations | |
CN101735134A (en) | Chiral 3-hydroxy pyrrolidone compound and preparation method and application thereof | |
CN115850150A (en) | Method for synthesizing 3-tetrasubstituted indoline-2-ones in one pot | |
CN101775035A (en) | Synthesis of class of amino acid type amphoteric water-soluble chiral phosphine ligand and application thereof in asymmetric catalytic hydrogenation | |
Pérez-Gómez et al. | Palladium-Mediated Functionalization of Benzofuran and Benzothiophene Cores | |
CN105085563B (en) | A kind of branch allyl compound, preparation method and application | |
CN112851708A (en) | Method for preparing olefine aldehyde by catalyzing terminal alkyne or terminal conjugated eneyne and diphosphine ligand used by method | |
CN109867691B (en) | Aryl amine derivative and preparation method and application thereof | |
CN109384718B (en) | A kind of chiral isoquinolinone compound and preparation method thereof | |
CN111825508B (en) | A kind of preparation method of dihydro-9-phenanthrene amine compound and chiral product obtained therefrom | |
JP2001026580A (en) | Method for producing optically active 1-aryl-1,2,3,4-tetrahydroisoquinolines | |
Khiar el Wahabi et al. | New sulfur-phosphine ligands derived from sugars: synthesis and application in palladium-catalyzed allylic alkilation and in rhodium asymmetric hydrogenation | |
CN108727179A (en) | A kind of alpha, beta-unsaturated ketone of α-allyl substitution, the synthetic method of ester or nitrile compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |